Digital Library
Close Browse articles from a journal
 
   next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             1155 results found
no title author magazine year volume issue page(s) type
1 Abstract converted to O-09.
100-101 S p. S38
article
2 Abstract converted to O-26.
100-101 S p. S56
article
3 Abstract converted to P-85
100-101 S p. S11
article
4 ABSTRACT REVIEWERS
100-101 S p. iii
article
5 ABSTRACT REVIEWERS
100-101 S p. ii
article
6 ABSTRACT REVIEWERS
100-101 S p.
article
7 Abstract withdrawn.
100-101 S p. S53
article
8 Abstract withdrawn.
100-101 S p. S38
article
9 Abstract withdrawn.
100-101 S p. S47
article
10 Abstract withdrawn.
100-101 S p. S61
article
11 Abstract withdrawn.
100-101 S p. S61
article
12 Accelerator-produced actinium-225 under the US DOE Tri-Lab collaboration: 2022 update Burgoyne, Andrew

100-101 S p. S42-S43
article
13 Accelerator production of 71As from metal germanium targets Lo, Yi-Hsuan

100-101 S p.
article
14 Access to 18F-labeled FAP inhibitor variants via [18F]SuFEx reaction Kogler, Jürgen

100-101 S p. S16
article
15 227Ac Content in Tri-Lab Accelerator-Produced 225Ac: 2023 Update Burgoyne, Andrew

100-101 S p.
article
16 225Ac labeled anti-HER2 2Rs15d sdAb as a potential therapeutic for targeted alpha therapy – an in vitro and in vivo evaluation Rodak, Magdalena

100-101 S p. S33
article
17 A clickable C-glycosyl scaffold for RGD peptide dimer labelling and application in bimodal [18F]PET/NIRF imaging Jouad, Kamal

100-101 S p. S42
article
18 A Comparison of Cation Exchange and Extraction Resin Column-based Chromatography Methods for Isolating MURR Produced 161Tb Bokolo, Patrick

100-101 S p.
article
19 A comparison of rhenium isolation and tungsten recovery methods from bulk tungsten targets Charles, Anster

100-101 S p. S104
article
20 A convenient tritiation strategy for tetrazines Bidesi, Natasha

100-101 S p. S90
article
21 Actinium-225 labeling of DOTATATE and DOTA-JR11 for the treatment of SSTR2-positive tumors Handula, Maryana

100-101 S p. S191
article
22 Advances in the automation technologies within LARAMED project Martini, Petra

100-101 S p. S21
article
23 A facile 18F radiochemistry of making (-)-[18F]TZ8024 for imaging VAChT and initial metabolite analysis in rat plasma and brain Zhao, Haiyang

100-101 S p. S39
article
24 A facile radiosynthesis of [18F]FBA-Pep42, a cyclic peptide targeting glucose-regulated protein 78 (GRP78) Yang, Hao

100-101 S p. S72
article
25 A facile synthesis of beta-amyloid PET imaging agent [18F]Florbetaben Akula, Hari

100-101 S p. S85
article
26 A fluorescent probe as a lead compound for a potential α-syn PET tracer: design and development of a library of RB1 derivatives Di Nanni, Adriana

100-101 S p. S94
article
27 A fluorescent probe as a lead compound for a selective α-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB Di Nanni, Adriana

100-101 S p.
article
28 A 68Ga-labeled linear peptide-based PET radiotracers for imaging PD-L1 status in tumors Hu, Kuan

100-101 S p.
article
29 A kit-based approach to aluminium-[18F]fluoride-labelled microbubbles and their in vivo biodistribution following ultrasound-targeted microbubble destruction Teh, Jin Hui

100-101 S p.
article
30 Albumin binders: a potential strategy for enhanced treatment of NETs using SSTR2 antagonists Koustoulidou, Sofia

100-101 S p. S191-S192
article
31 Al18F-Radiolabeling of PSMA-11 in a media of protic ionic liquids Antuganov, Dmitrii

100-101 S p. S76-S77
article
32 ALISI – automated light-induced synthesis of 89Zr-labelled antibodies for immuno-PET Klingler, Simon

100-101 S p. S5-S6
article
33 Alpha particle therapy for the treatment of metastatic tumors of prostate cancer Bidkar, Anil

100-101 S p.
article
34 Alternate radiohalogens for trametinib PET imaging Pratt, Edwin

100-101 S p. S52
article
35 Alternative protective group strategy for the radiosynthesis of Flortaucipir 18F Xiong, Hui

100-101 S p. S88
article
36 A 177Lu-labeled anti-HER2 dual variable domain antibody MacPherson, Douglas

100-101 S p. S9
article
37 A multi-modality platform employing supramolecular chemistry to radiolabel antibodies d’Orchymont, Faustine

100-101 S p. S27-S28
article
38 A multimodal SPECT: photoacoustic imaging agent for bacterial infection Swann, Rowan

100-101 S p. S62-S63
article
39 Analysis beyond the image, new prospects in α autoradiography Donnard, Jerome

100-101 S p.
article
40 Analysis of radiochemical stability and in vivo distribution of recoiled 213Bi from [225Ac]Ac-DOTATATE in preclinical model Dijie, Liu

100-101 S p.
article
41 An approach towards reverse generator system for 99mTc separation from LSA 99Mo Cieszykowska, Izabela

100-101 S p. S97
article
42 An effective process for radiolabelling of bioactive amines from 2,2-difluoro-2-[18F]Fluoro-ethyl 4-methylbenzenesulfonate, a versatile tool for 18F-radiotracer development Maqbool, Mudasir

100-101 S p. S82
article
43 An Evaluation of the Production of High Specific Activity 155Tb via Alpha-Irradiation of Thick Natural Eu2O3 and Enriched [153Eu] Eu2O3 Targets Charles, Anster

100-101 S p.
article
44 A new in silico approach to revolutionize CNS PET tracer design and enhance translational success Jackson, Isaac

100-101 S p. S24-S25
article
45 A new paradigm of cancer immunotherapy based on [18F]FDG and anti-PD-L1 mAb combination Wen, Xuejun

100-101 S p. S219-S220
article
46 A new phenylstannyl precursor for synthesizing [11C]UCB-J Mori, Wakana

100-101 S p.
article
47 A new prospective CB2 receptor tracer based on a 18F labelled naphthyridine core: radiosynthesis and microPET imaging data Pascali, Giancarlo

100-101 S p. S35
article
48 A new rhenium/technetium-99m complex bearing a quinazoline derivative and 2-picolylamine-N-acetic acid for EGFR imaging Makrypidi, Konstantina

100-101 S p. S15
article
49 An improved separation scheme for 44Sc purification from proton irradiated calcium Kurakina, Elena

100-101 S p. S92
article
50 An improved synthesis of [18F]VAT precursor for a one-step radiofluorination Hu, Bao

100-101 S p. S85-S86
article
51 An interleukin-2 derived small peptide probe for CD25 targeted PET/CT imaging of activated T cells Wang, Shuailiang

100-101 S p. S7
article
52 An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks Braband, Henrik

100-101 S p. S32-S33
article
53 A novel building block facilitates the synthesis of the 89Zr-Chelator DFO* Feiner, Irene

100-101 S p.
article
54 A novel 18F-labeled reversible PET ligand for imaging monoacylglycerol lipase Rong, Jian

100-101 S p.
article
55 A novel flexible pipetting-based platform for automated microvolume radiochemistry Lu, Yingqing

100-101 S p. S58-S59
article
56 A novel fluorine-18 labeled P2Y12 receptor PET tracer for imaging of anti-inflammatory microglia van der Wildt, Berend

100-101 S p. S108-S109
article
57 A novel PET ligand for imaging monoacylglycerol lipase in naïve and mouse models of Alzheimer’s disease Rong, Jian

100-101 S p. S21
article
58 A Novel Prosthetic group, 4-[18F]Fluorophenylglyoxal for Protein Conjugation Sadasivam, Pragalath

100-101 S p.
article
59 A Novel Purification Method to Improve the Chemical Purity of the 203Pb/212Pb Theranostic Pair McNeil, Brooke

100-101 S p.
article
60 A novel radioiodinated probe for diagnosis of systemic amyloidosis based on thioflavin-T and Congo-red hybrid structure Haratake, Yoshie

100-101 S p. S54-S55
article
61 A novel radioiodination method for the preparation of radiopharmaceuticals Debnath, Shuvra

100-101 S p.
article
62 A novel radiotracer for imaging autotaxin: [18F]THPDPATX Ebrahimi, Edris

100-101 S p. S186
article
63 A novel synthesis of [11C]FTIMD Ishii, Hideki

100-101 S p.
article
64 A novel tetrahydrothienopyridine-based PET tracer for P2Y12 receptor imaging in the brain Joseph, Emanuel

100-101 S p. S47
article
65 Antibody-based PET imaging of alpha-synuclein Syvaenen, Stina

100-101 S p.
article
66 Antibody-based radioligands can distinguish between amyloid-beta subtypes beyond [11C]PiB-positive pathology Syvaenen, Stina

100-101 S p.
article
67 Anti-EphA2 Minibody as a targeting antibody for the molecular imaging of fibrosarcoma tumors. Birikorang, Peggy

100-101 S p.
article
68 Antigen-dependent inducible T cell reporter system for PET imaging of tumor specific antigens Shin, Jaehoon

100-101 S p.
article
69 Antimicrobial peptide form native plant Erythrina crista-galli: a promising agent for diagnostic of infection foci Osorio, Jessica

100-101 S p. S72-S73
article
70 A pilot study of [18F]AlF-HER2 Affibody in HER2-positive breast cancer patients Guo, Xiaoyi

100-101 S p. S49
article
71 Application of ionic liquids for ring-opening of non-activated aziridines with [11C]CO2 Lindberg, Anton

100-101 S p. S28-S29
article
72 Application of Machine Learning Driven Computational Approaches for Novel CNS PET Tracer Development Jackson, Isaac

100-101 S p.
article
73 Application of quaternary 1,4-diazabicyclo[2.2.2]octan (DABCO) salts for SN2 “minimalist” radiofluorination Keuthen, Yannick

100-101 S p. S49
article
74 A Practical Production of Clinical Interesting Radiotracer [11C]UCB-J Akula, Hari

100-101 S p.
article
75 Apramer-based synthesis of radiopharmaceuticals Belugin, Kirill

100-101 S p. S179
article
76 A preclinical platform for the radiolabelling and in vivo monitoring of nanoparticles against Crohn’s Disease using live dynamic SPECT imaging Karampelas, Theodoros

100-101 S p. S54-S55
article
77 A Preclinical Platform to Thoroughly Evaluate Novel Nanocomposites in the Full Spectrum of Drug Discovery (in vitro - in vivo - ex vivo) Towards Cancer Treatment Sarpaki, Sophia

100-101 S p.
article
78 A Preliminary Study of the Ortho Effect on Radiofluorinations Using Aryl Sulfonium Salt Precursors Zhang, Wei

100-101 S p.
article
79 A pretargeting approach to PET imaging with antibodies Penawou, Pamela

100-101 S p. S59-S60
article
80 A pyrene-phthalocyanine conjugate for dual Cherenkov radiation-induced near-infrared luminescence imaging and photodynamic therapy lioret, Vivian

100-101 S p. S105-S106
article
81 A quest for simplicity: automated cassette-based purification of [61Cu]CuCl2 from solid Ni targets using a single time-list Svedjehed, Johan

100-101 S p. S170
article
82 A rapid non-radiometric LC-MS/MS procedure for measuring the molar activity of cyclotron-produced [18F]fluoride Ellin, Nicholas

100-101 S p.
article
83 Aryliodonium ylides as efficient precursors for astatine-211 labeling Maingueneau, Clémence

100-101 S p. S174-S175
article
84 Arylpalladium complexes on solid supports for convenient last-step labelling of bioconjugates by [11C]CO Hermange, Philippe

100-101 S p. S72
article
85 A side-by-side comparison of a monomer- versus a dimer-based 68Ga- and 177Lu-labeled FAP inhibitor for theranostic tumor stroma targeting Läppchen, Tilman

100-101 S p.
article
86 A simple and fully automatic production of [18F]SMBT-1 using an All-in-One chemistry module Ko, Nare

100-101 S p.
article
87 A simplified radiosynthesis of [18F]FMPEP for imaging CB1 receptors Pees, Anna

100-101 S p. S83
article
88 A single-pot photo-induced reaction for zirconium-89 radioimmunoPET agents: an efficient approach for translation of radiolabeled antibodies for human use Fong, Cyril

100-101 S p. S119-S120
article
89 Assessing the binding affinity of a 64Cu-labeled PSMA ligand in a micro physiological system Sihver, Wiebke

100-101 S p.
article
90 Assessment for anti-fatigue effect of traditional oriental medicine via PET/CT Park, Sun Mi

100-101 S p.
article
91 Assessment of [64Cu]Cu-FAP-2286 in immunocompetent mice bearing pancreatic ductal adenocarcinoma (PDAC) tumors Seo, Jai Woong

100-101 S p.
article
92 Assessment of novel mesothelin specific human antibody VH-Fc fusion proteins-based PET agents Cortez, Angel

100-101 S p.
article
93 Assessment of the influence of [18F]florastamin isomer on pharmacokinetic properties for prostate cancer diagnosis: preclinical comparison of biodistribution Lee, Kyongkyu

100-101 S p.
article
94 A stable and robust production process of [18F]fluorodeprenyl-D2 using a cassette-type chemistry module Ko, Nare

100-101 S p.
article
95 Astatine-211 based PSMA-inhibitors for targeted alpha-therapy of prostate cancer Poulie, Christian

100-101 S p. S60
article
96 A structure-activity relationship study of bimodal BODIPY-labeled PSMA-targeting bioconjugates Stemler, Tobias

100-101 S p. S26-S27
article
97 A study to obtain a highly reproducible radiochemical yield (RCY) in the PSMA-11 radiolabeling Iudicello, Antonella

100-101 S p. S142-S143
article
98 At-211-labeled L-tyrosine derivatives via neopentyl scaffold for targeted α-therapy Kaizuka, Yuta

100-101 S p. S12-S13
article
99 A trifluoroborate (BF3) radioprosthetic group bearing FAP-targeting ligand for facile labeling with 18F via the 18F-19F isotope exchange reaction: synthesis, radiolabeling and in vivo evaluation Bendre, Shreya

100-101 S p. S179-S180
article
100 Auger electrons in radionuclide therapy: Szilárd-Chalmers effect/hot atom chemistry during the targeted delivery of the isotopes Szucs, Zoltán

100-101 S p.
article
101 Au@Pt core-shell nanoparticle bioconjugates for Auger electron radiotherapy – preliminary studies Wawrowicz, Kamil

100-101 S p. S82-S83
article
102 Author Index
100-101 S p. S223-S235
article
103 AUTHOR INDEX
100-101 S p. S76-S81
article
104 Author Index
100-101 S p. S109-S114
article
105 Author Index
100-101 S p.
article
106 Automated cassette based synthesis of novel CB1 receptor tracer [18F]FPATPP produced via Ru-mediated 18F-fluorination Rajala, Noora

100-101 S p.
article
107 Automated Clinical Radiosynthesis of [18F]-F-AraG using the Elixys FLEX/CHEM and PURE/FORM Synthesis System Deyerle, Phillip

100-101 S p.
article
108 Automated 18F-Al-radiolabelling optimization of PSMA-11 for PET imaging using a design of experiments approach Wagner, Laurène

100-101 S p. S138-S139
article
109 Automated multidoses production of [68Ga]PentixaFor in general purpose commercial module and its preclinical evaluation in lymphoma model Sahu, Sudeep

100-101 S p. S211
article
110 Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter Tu, Zhude

100-101 S p.
article
111 Automated production of [18F]AldoView: first translation of a sulfonium salt precursor to GMP Sirindil, Fatih

100-101 S p. S137
article
112 Automated production of sodium [11C]butyrate Pakula, Ryan

100-101 S p. S70-S71
article
113 Automated purification of 18F-compounds by semi-preparative supercritical fluid chromatography (SFC) Maindron, Nicolas

100-101 S p. S22-S23
article
114 Automated purification of radiometals produced by solid targets Gongora-Servin, Benito

100-101 S p.
article
115 Automated radiolabeling of [68Ga]Ga-DOTATOC using the iMiDEV™ automated microfluidic radiosynthesizer Chandrashekara, Hemantha Kumara

100-101 S p. S122-S123
article
116 Automated radiosyntheses of [18F]FMPEP-d 2 and [18F]MAGL-2102 for imaging the endocannabinoid system Pees, Anna

100-101 S p.
article
117 Automated radiosynthesis of [18F]AlF-FAPI-42 Gröner, Benedikt

100-101 S p. S61-S62
article
118 Automated radiosynthesis of [18F]AV-45 using Elixys FLEX/CHEM and PURE/FORM synthesis system Miller, William

100-101 S p. S132
article
119 Automated radiosynthesis of [18F]DOPA and [18F]FMT via copper-mediated nucleophilic F-18 Fluorination of arylstannanes on a new synthesizer Nagachinta, Surasa

100-101 S p. S133-S134
article
120 Automated radiosynthesis of 6-[18F]F-L-DOPA from a boronic precursor on NEPTIS® module Maindron, Nicolas

100-101 S p. S129
article
121 Automated radiosynthesis of [18F]FMeNER-D2 using the simplified one-pot 18F-fluoromethylation. Zhang, Ming-Rong

100-101 S p.
article
122 Automated radiosynthesis of meta-[18F]Fluorobenzylguanidine from a diaryliodonium salt precursor on NEPTIS® module Maindron, Nicolas

100-101 S p. S131
article
123 AUTOmated radiosynthesis of para-[131I]Iodo-L-phenylalanine on NEPTIS® module Maindron, Nicolas

100-101 S p. S130-S131
article
124 Automated radiosynthesis of the 18F-labeled BF2-chelated tetraaryl-azadipyrromethenes photosensitizer using isotopic exchange Kawamura, Kazunori

100-101 S p. S81-S82
article
125 Automated synthesis and quality control of [18F]FFNP with GMP compliance Kim, Dong Hyun

100-101 S p. S127-S128
article
126 Automated synthesis of D-[3-11C]Alanine on the Sofie Biosciences Elixys Flex/Chem Simpson, Spenser

100-101 S p. S136-S137
article
127 Automated synthesis of 16-[131I]iodohexadecanoic acid: a lymphatic leakage tracer Plhak, Elisabeth

100-101 S p. S59-S60
article
128 Automation of 4-[18F]fluorogabapentin radiosynthesis Zhou, Yu-Peng

100-101 S p. S66
article
129 Automation of two-step one-vessel ditosylate synthon fluorination using Trasis AllinOne Lee, Hsiaoju

100-101 S p.
article
130 Automation of two-step synthesis of [18F]FP-TMP using Trasis AllinOne Lee, Hsiaoju

100-101 S p. S127
article
131 A versatile cassette-based adaptor for solid targets dissolution on commercial synthesis modules Sciacca, Gabriele

100-101 S p. S46-S47
article
132 3-Aza-6-[18F]fluoro-isatoic anhydrides ([18F]AFIAs) - novel prosthetic groups for indirect radiolabeling Willmann, Michael

100-101 S p. S28
article
133 131Ba as a promising SPECT-diagnostic match for 223/224Radium Reissig, Falco

100-101 S p. S95
article
134 Behind the scenes of Ga-68-Trivehexin development: unique structure-activity relationships Quigley, Neil

100-101 S p. S208-S209
article
135 8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for PET imaging of the A1 adenosine receptor Holschbach, Marcus

100-101 S p. S26-S27
article
136 Bifunctional [2.2.2]-cryptands: Selective and efficient chelators for the 203Pb/212Pb theranostic pair McDonagh, Anthony

100-101 S p.
article
137 Binding of [64Cu]DOTATATE beyond the BBB Andersen, Ida

100-101 S p. S172-S173
article
138 Bioconjugates labeled with Auger electron emitter: 135La, as potential therapeutic radiopharmaceutical Walczak, Rafał

100-101 S p. S159
article
139 Bioconjugates of 103Pd/103mRh in-vivo generator for targeted Auger electron therapy Gieraltowska, Joanna

100-101 S p. S188-S189
article
140 Biodistribution of a 67Ga-labeled anti-TNF VHH single-domain antibody containing a bacterial albumin-binding domain (Zag) Morais, Maurício
2014
100-101 S p. e44-e48
nvt p.
article
141 Biodistribution of [89Zr]DFO-Maleimide-VLP-1 in Wistar Rats by Positron Emission Tomography (PET) Riffel, Kerry

100-101 S p.
article
142 Biological evaluation of [18F]FDG-Tz as a tracer candidate for pretargeted PET imaging Auchynnikava, Tatsiana

100-101 S p. S71-S72
article
143 Biological evaluation of 111In-clickable complexes for cancer theranostics D’Onofrio, Alice

100-101 S p. S188
article
144 Bioorthogonal chemistry approach for theranostics of GRPR-expressing cancers Gano, Lurdes

100-101 S p. S30
article
145 2,6-Bis-(N-hydroxylamino)-1,3,5-triazines as ligands for 45Ti-chelation Hoffmann, Chris

100-101 S p.
article
146 Bispecific antibody-based radiopharmaceutical towards phosphorylated TDP-43 Pakula, Ryan

100-101 S p. S103
article
147 Bispidine - One chelator to bind lutetium-177 and actinium-225 Brühlmann, Santiago

100-101 S p.
article
148 Bispidin-9-ol derivatives for copper-64:67 radiolabeling and facile biofunctionalization strategies Wünsche, Adrian

100-101 S p. S74-S75
article
149 Blood–brain barrier penetrating peptide-based radioligands targeting the EGFR:EGFRvIII receptors Schuderer, Franziska

100-101 S p. S71-S72
article
150 Blood-brain barrier permeable antibodies for brain imaging van den Broek, Sara Lopes

100-101 S p.
article
151 Borylation and 18F-Fluorination of arenes mediated by Lewis-acid organocatalysts Garcia, Raul Perez

100-101 S p. S84
article
152 Brain energetics by biomedical modalities Tiwari, Anjani

100-101 S p. S108
article
153 Bringing personalized medicine to the next level: RANKL immuno-PET imaging using [64Cu]Cu-NOTA-anti-RANKL-Fab fragments Dewulf, Jonatan

100-101 S p. S184-S185
article
154 Bucherer-Bergs multicomponent reaction with [11C]CO2, a facile and divergent synthesis of 11C-labelled hydantoins van der Aa, Frank

100-101 S p. S75
article
155 Cancer theranostics using radiolabelled PARP inhibitors Ferrat, Mélodie

100-101 S p.
article
156 Can the Radiochemical Purity of 225Ac-Labeled Compounds be Accurately Assessed by Radio-TLC Alone? Wacker, Anja

100-101 S p.
article
157 Capsular reformulation of the PET radiopharmaceutical [18F]FTHA for oral administration Moerlein, Stephen

100-101 S p. S144
article
158 Carbamoyl fluoride as a potential new tag for 18F-labeling Bonnefoy, Clémence

100-101 S p. S77-S78
article
159 Carbasugars synthesis and derivatization: a new labelling strategy with 99mTc for infection diagnostic agents Gretter, Mariella Terán

100-101 S p. S40-S41
article
160 Carbon-11 carboxylation of trialkoxysilane and trimethylsilane derivatives using [11C]CO2 Bongarzone, Salvatore

100-101 S p. S68
article
161 Carbon-11 labelled isocyanides: new versatile building blocks to access novel PET tracers Bonnemaire, Coralie

100-101 S p. S27-S28
article
162 Carbon-11 Labelling of Benzenesulfonamide Analogues as Novel Radiotracers to Visualize the Pore-forming Activity of Perforin Zhang, Bo

100-101 S p.
article
163 Cationic pH-responsive albumin binding ligands (ABLs) for enhanced cancer-specific theranostics Lee, Jeong-Seob

100-101 S p.
article
164 11C-Carbonylation using TracerLab FX Synthesis modules Shao, Xia

100-101 S p. S136
article
165 [11C]Carboxylated tetrazines for facile labeling of trans-cyclooctene-functionalized macromolecules Vázquez, Rocío García

100-101 S p. S71-S72
article
166 11C-Carboxylation via organic photoredox-catalyzed isotopic exchange Munch, Maxime

100-101 S p. S29
article
167 CD46 targeted, Actinium-225 labelled antibody for treatment of prostate cancer xenografts Bidkar, Anil

100-101 S p. S31
article
168 CD133-Targeted Radioimmunotherapy of Small Cell Lung Cancer Sebastiano, Joni

100-101 S p.
article
169 Cell membrane localization of terbium-161 using peptide receptor antagonists: can we profit from Auger electron emission with non-internalizing targeting agents? Müller, Cristina

100-101 S p. S26
article
170 Centralized GMP production of [90Y]Y-PentixaTher for clinical trials Berroteran-Infante, Neydher

100-101 S p. S121
article
171 Cerenkov Luminescence Signal Enhancement using Hyperbolic Metamaterials as a Multi-modal Imaging Probe Boykoff, Natalie

100-101 S p.
article
172 cGMP synthesis of 4-[18F]fluoro-1-naphthol, a novel PET tracer for imaging activation of innate immunity Pisaneschi, Federica

100-101 S p.
article
173 11C-guanylated histamine for PET cardiac imaging Mhanna, Karim

100-101 S p.
article
174 C-H activation: optimisation of palladium mediated 11C methylation Ariztia, Julen

100-101 S p. S70
article
175 Characterization of a PET radioligand suitable for imaging and quantification of sigma-2 receptor in the primate brain Zheng, Ming-Qiang

100-101 S p. S5
article
176 Characterization of new FSHβ-derived peptide probes for the validation of FSHR as a new prognostic and predictive biomarker in primary and metastatic cancers Carpanese, Debora

100-101 S p. S89
article
177 Chelation of Manganese - 52 for development of long-lived PET radiopharmaceuticals Omweri, James

100-101 S p.
article
178 Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-64 Krutzek, Fabian

100-101 S p. S38
article
179 Chemically Identical Pair of Theranostic Small-Molecule Drug Conjugates for Prostate Cancer Imaging and Chemotherapy Hao, Guiyang

100-101 S p.
article
180 Chemoenzymatic Synthesis of Fluorine-18-Labelled Disaccharides Used for PET Imaging of Bacteria Infection Sorlin, Alexandre

100-101 S p.
article
181 Cholesterol-depleting drugs for HER2-targeted radioimmunotherapy of patient-derived esophagogastric (EG) cancer Rao, Yi

100-101 S p. S210-S211
article
182 Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues Donat, Cornelius

100-101 S p. S220
article
183 Chromophore-conjugated NCS-activated NODAGA is a versatile tool for quantitative prediction of protein-chelator conjugation for 64Cu-immunoPET Seyfried, Dominik

100-101 S p. S10-S11
article
184 [11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics Cools, Romy

100-101 S p.
article
185 11C-labelled oxadiazoles via 11C-labelled acyl amidines through a one-pot, two-step reaction Rydfjord, Jonas

100-101 S p. S74
article
186 Click-cleavable 111In/177Lu-labeled DOTA-TCO-trastuzumab for imaging and therapy of breast cancer de Roode, Kim

100-101 S p. S16
article
187 Clinical grade [15O]O2 Production for Human Inhalation PET/MRI study Park, Jun Hyung

100-101 S p.
article
188 Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors Orlova, Anna

100-101 S p. S58
article
189 11C-MePro PET/CT Imaging in Normal Volunteers: Initial Evaluation of PET-based Human Biodistribution Yamazaki, Kana

100-101 S p.
article
190 [55Co]Co-DOTA-SP4: Towards NK1R-targeted Theranostics of Glioblastoma Laursen, Vigga

100-101 S p.
article
191 Combined PD-L1–targeted radionuclide therapy with immunotherapy in two models of colorectal cancer Wen, Xuejun

100-101 S p. S33
article
192 Combining Positron Emission Tomography and Hyperpolarized Magnetic Resonance to Interrogate Prostate Cancer Metabolism Enriquez, Jose

100-101 S p.
article
193 Come up smelling of roses – Using a real-time radioligand assay to elucidate PD-L1 binding of different ligand classes Donat, Cornelius

100-101 S p.
article
194 Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy Gouard, S.
2014
100-101 S p. e30-e35
nvt p.
article
195 Comparative evaluation by SPECT and PET imaging of two immuno-pre-targeting systems in an in vivo model of triple negative breast tumours with anti-EGFR antibodies Briat, Arnaud

100-101 S p. S204-S205
article
196 Comparative evaluation of 177Lu-DOTATATE and 90Y-DOTATATE in SSTR II overexpressing Xenograft models for treatment of variable volume neuroendocrine tumours Tawate, Megha

100-101 S p. S213-S214
article
197 Comparative in vivo biodistribution and dosimetry in non-human primate of the fibroblast activation protein radiotracers [68Ga]Ga-FAPI-04, [68Ga]Ga-FAPI-46 and [18F]FAPI-74 Tran, Thuy

100-101 S p. S216-S217
article
198 Comparative in vivo PET/CT, biodistribution, and excretion study of Cu-64 labeled Polypropylene (PP) nanoplastics via various administration routes in mice Kwon, Mihye

100-101 S p.
article
199 Comparing the day-to-day production of [68Ga]Ga-PSMA-11 using Locametz and Illuccix Kits Wang, Ivan

100-101 S p.
article
200 Comparison of a radiolabeled somatostatin agonist with an antagonist using the SSTR2 expressing cell line BON-1S in 2D and 3D models Sihver, Wiebke

100-101 S p. S212-S213
article
201 Comparison of biodistribution according to administration route for the development of liposome therapeutics Yoo, Ran Ji

100-101 S p. S165
article
202 Comparison of [11C] and [18F] labelled D-amino acid tracers for imaging of bacterial infection Lopez-Alvarez, Marina

100-101 S p.
article
203 Comparison of cyclotron produced manganese-52 from natural chromium and vanadium targets Nielsen, Karin Michaelsen

100-101 S p. S171-S172
article
204 Comparison of DOTA, NODAGA and 15-5 macrocycles as chelators for 64Cu-labelling of immunoconjugates Maisonial-Besset, Aurélie

100-101 S p. S153-S154
article
205 Comparison of Evans Blue vs 4-(p-iodophenyl)butyric acid albumin binding moieties for lutetium-177-labeled LLP2A derivatives as theranostic agents for metastatic melanoma Pun, Michael

100-101 S p. S61
article
206 Comparison of [18F]FEOBV, [3H]VAT, [3H]MK-6884 and [3H]JNJ-64511070 for imaging Alzheimer’s disease d’Orchymont, Faustine

100-101 S p.
article
207 Comparison of [18F]PSMA-1007 with Novel 18F-Labeled PSMA Inhibitor Donat, Cornelius

100-101 S p.
article
208 Comparison of [68Ga]Ga precursors for blood cell radiolabeling Bouvry, Christelle

100-101 S p. S57
article
209 Comparison of the Biodistribution of [18F]FNP-59 and its Esters Brooks, Allen

100-101 S p.
article
210 Comparison of the syntheses of 18F-labelled norepinerphrine transporter tracer [18F]NS12137 using in-house built device and Trasis AllinOne Rajala, Noora

100-101 S p.
article
211 Comparison of two cyclen-based phosphonates for development of bone-seeking lutetium-177 radiopharmaceuticals Mitrofanov, Iurii

100-101 S p. S70-S71
article
212 Comparison of Voxelized Monte Carlo and OLINDA Dosimetry Methods Towards 67Cu-LLP2A Therapy from 64Cu-LLP2A PET/CT Imaging Data Bellavia, Michael

100-101 S p.
article
213 Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer Ho, Van

100-101 S p.
article
214 Complexation of [186Re][Re(CO)3]+ and [99mTc][Tc(CO)3]+ cores with TACN-based chelators Hoerres, Rebecca

100-101 S p.
article
215 Computational design, synthesis and radiolabelling of a novel octacoordinate chelator for 89Zr Klingler, Simon

100-101 S p. S45-S46
article
216 Conception of Nanoparticles as Diagnostic Agents Mignet, Nathalie

100-101 S p. S2-S3
article
217 CONTENTS
100-101 S p. iii
article
218 Contents 2014
100-101 S p. IBC-
1 p.
article
219 CONTENTS
100-101 S p.
article
220 Convenient preparation of 18F-labeled human insulin by Pd-catalyzed S-arylation Humpert, Swen

100-101 S p. S116-S117
article
221 Copper-61 as an alternative to Gallium-68 for radiopharmaceutical production: feasibility study and scale-up for clinical doses Fonseca, Alexandra

100-101 S p. S21-S22
article
222 Copper catalyzed radiobromination of boronic pinacol esters: utility in PARP inhibitor synthesis Mixdorf, Jason

100-101 S p. S175
article
223 Copper-free click labeling with the [99mTc]Tc-tricarbonyl-core using DACN derivatives Mamat, Constantin

100-101 S p. S37
article
224 Copper-61 from liquid targets: optimized purification for GMP labelling Fonseca, Alexandra

100-101 S p. S98-S99
article
225 Copper-mediated 18F-fluorination of boroxines: a systematic optimization study Bolik, Kim-Viktoria

100-101 S p. S35-S36
article
226 Copper mediated radiocyanation of aryl halides Sharninghausen, Liam

100-101 S p. S29-S30
article
227 Corrole radiolabelling with 68Ga, 64Cu and 67Cu - a novel approach for theranostic applications in cancer Ekaney, Thomas Kolle

100-101 S p.
article
228 Covalent Modification of Black Phosphorus Nanosheets with 89-Zirconium Shen, Jieting

100-101 S p.
article
229 11C-Radiolabeling of α-amino acids via aldehyde-promoted isotopic exchange reaction Munch, Maxime

100-101 S p. S29
article
230 C(sp3)-H functionalization for access to [11C]amino acids Edgar, Fraser

100-101 S p. S68-S69
article
231 64Cu-DOTHA2-PSMA, a novel theranostic agent for prostate cancer and its preclinical animal evaluation Milot, Marie-Christine

100-101 S p. S105
article
232 Cu-64 heterodimers targeting GRPR: PSMA expressing cells: in vitro and in vivo investigations Chambers, Claudia

100-101 S p. S8
article
233 64Cu-labeled fucoidan nanoparticles for non-invasive PET/CT tumor imaging Kim, Kyungwon

100-101 S p.
article
234 64Cu-labeled panitumumab for PET imaging of EGFR+ non-small cell lung cancer: Subcutaneous and metastatic mouse models Wuest, Frank

100-101 S p.
article
235 64Cu-labeled TCP-1 probe for PET imaging of colorectal cancer Li, Feng

100-101 S p.
article
236 64Cu-Lazarus: bringing our [64Cu]CuCl2 manufacturing system back to life Stimson, Damion

100-101 S p.
article
237 Cu-mediated 18F-radiofluorination of various stannylated FDOPA precursors – what is feasible? Kniess, Torsten

100-101 S p.
article
238 64Cu production via the 68Zn(p,nα)64Cu nuclear reaction: Targetry, radiochemistry and PET imaging for utility assessment Nelson, Bryce

100-101 S p.
article
239 Curcumin-based 68Ga-radiotraces: radiolabeling strategies and bifunctional chelator approach Mari, Matteo

100-101 S p. S69
article
240 Current developments in the production of actinium-225 from thorium-229 Benny, Paul

100-101 S p. S42
article
241 [11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor Högnäsbacka, Antonia

100-101 S p.
article
242 Cyclic [68Ga] and [18F]AlF-labeled peptides for specific detection of human angiotensin-converting enzyme 2 Wilson, David

100-101 S p. S64-S65
article
243 CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes Jaworski, Carolin

100-101 S p.
article
244 Cyclotron-based Production of Lanthanum-133 with High Radionuclidic Purity for Theranostic Purposes Brühlmann, Santiago

100-101 S p.
article
245 Cyclotron Production of Copper-67: Exploring the limits Brühlmann, Santiago

100-101 S p.
article
246 Cyclotron production of gallium-68 from liquid target: routine production of 68Ga-labelled radiotracers Uhlending, Antje

100-101 S p. S151
article
247 Cyclotron-production of manganese-52 for multi-modal imaging applications Boschi, Alessandra

100-101 S p. S46
article
248 Cyclotron-production of Mn-52: an update on the METRICS project Martini, Petra

100-101 S p. S169-S170
article
249 Cyclotron production of the 64Cu theranostic radiometal using a novel 68Zn sealed solid target Nelson, Bryce

100-101 S p. S171
article
250 Cyclotron production of the theranostic pair 133/135La for nuclear medicine Nelson, Bryce

100-101 S p. S2-S3
article
251 Cytotoxicity of the bimodal [224Ra]RaCl2 and [212Pb]Pb-TCMC-TP-3 solution in a multicellular tumor spheroid model of osteosarcoma Tornes, Anna Julie

100-101 S p. S15-S16
article
252 Delayed 64Cu-DOTA-Rituximab PET image generation for dosimetry using paired image-to-image translation Kim, Kangsan

100-101 S p.
article
253 Demonstrating peptide based nanoconstructs as emerging theranostic biomolecules Khan, Irfan

100-101 S p. S87-S88
article
254 Demonstration of intracellular pH-weighting PET imaging using a new-type PET probe responsible for monoacylglycerol lipase activity in the brain Yamasaki, Tomoteru

100-101 S p. S112-S113
article
255 De novo design of alpha-synuclein small molecule PET tracers Korat, Spela

100-101 S p. S97
article
256 De novo design of lead structures for P2Y12 receptor tracer development using in silico methods Stéen, E. Johanna

100-101 S p. S105-S106
article
257 Density functional theory experiments offer insight into properties of the Sc-HOPO complex Phipps, Michael

100-101 S p. S71
article
258 Design and evaluation of new 99mTc/188Re-labeled TSPO-binding ligands for cancer theragnostic Lee, Kyeongyang

100-101 S p.
article
259 Design and synthesis of a new bifunctional chelating agent for 18F-Al/177Lu radiolabelling: theranostic approach Wagner, Laurène

100-101 S p. S12-S13
article
260 Design and synthesis of fluorinated pyrazolidine-3,5-dione derivatives as potential P2Y12 receptor PET tracers Stéen, E. Johanna

100-101 S p.
article
261 Design and synthesis of monomeric ligands based on published EGFR (epidermal growth factor receptor)-specific peptides for the diagnostic application in malignant transformations Judmann, Benedikt

100-101 S p.
article
262 Design and synthesis of novel heptadentate chelates for 89Zr-radiolabelling of antibodies Guillou, Amaury

100-101 S p. S7
article
263 Designing and validating the nested neutron spectrometer using for accelerator-based neutron source: Monte Carlo code and artificial intelligence algorithm Tuan, Hoang

100-101 S p. S73
article
264 Design space approach to optimise the [68Ga]Ga-Pentixafor radiolabelling process Kaufmann, Jens

100-101 S p. S60
article
265 Design, synthesis and biological evaluation of a small-molecule PET imaging agent for imaging PD-L1 expression Xu, Liang

100-101 S p.
article
266 Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors Millard, Marlon

100-101 S p.
article
267 Design, Synthesis, and Evaluation of an 18F-Labeling Dendrimer Radiotracer for Positron Emission Tomography (PET) Imaging of Heparanase Pu, Yinglan

100-101 S p.
article
268 Detecting EGFR expression in bladder cancer using [89Zr]Zr-DFO-Panitumumab immunoPET imaging Hoang, Tran

100-101 S p. S194
article
269 Determination of Association Constants of Macropa-based Chelators for the Stable Complexation of Barium-131 and Lanthanum-133 Blei, Magdalena

100-101 S p.
article
270 Determination of 2-chloro-2-deoxy-D-glucose, 2-fluoro-2-deoxy-D-glucose, and glucose in [18F]Fluorodeoxyglucose by capillary electrophoresis Antuganova, Yulia

100-101 S p. S80
article
271 Developing a Novel Microfluidics-based 86Y Purification Strategy for Rapid and Efficient Radiopharmaceutical Production Ta, Robert

100-101 S p.
article
272 Development and application of a fully automated multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis Cui, Fang-Bo

100-101 S p.
article
273 Development and biological evaluation of 18F-labeled adenosine-A1-receptor partial agonists Evcüman, Sibel

100-101 S p. S9
article
274 Development and evaluation of fully automated F-18 cromolyn diethyl ester labeling via multi step reaction as potential therapeutics for Alzheimer’s Disease for brain PET imaging Moon, Sung-Hyun

100-101 S p.
article
275 Development and evaluation of new small molecule PET-radiotracers for the molecular imaging of inflammatory processes targeting S100A9 Steiner, Simon

100-101 S p. S44-S45
article
276 Development and evaluation of novel TSPO PET tracers with low binding sensitivity to human single nucleotide polymorphism rs6971 Beaino, Wissam

100-101 S p.
article
277 Development and evaluaton of a trans-cyclooctene (TCO) probe for pretargeted PET imaging Adhikari, Karuna

100-101 S p. S176
article
278 Development and exploration of bifunctional chelating ligands for mercury-197m/g Randhawa, Parmissa

100-101 S p. S13-S14
article
279 Development and First-in-Man Study of a Novel Tetrapeptidic CCK-2R-Targeted Compound with Improved Metabolic Stability and Pharmacokinetics Günther, Thomas

100-101 S p.
article
280 Development and initial evaluation of two [99mTc]Tc complexes derived from a fibroblast activating protein (FAP) inhibitor Decuadra, Paula

100-101 S p. S39-S40
article
281 Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma Métivier, Cassandra

100-101 S p. S203-S204
article
282 Development and in vivo Evaluation of a Novel 18F-labeled Aromatase Inhibitor PET Radiotracer in Rodent Models for Cancer Li, Songye

100-101 S p.
article
283 Development and preclinical evaluation of [11C]HSP990 as an Hsp90 PET brain probe and potential biomarker for diagnosis and follow up of CNS disease progression Cools, Romy

100-101 S p. S93-S94
article
284 Development and pre-clinical evaluation of new 64Cu-NOTA-folate conjugates for PET imaging of folate receptor-positive tumors Alhokbany, Norah

100-101 S p. S74
article
285 Development and preclinical evaluation of PSMA-targeting trimers based on the NOTI chelating platform Martin, Sebastian

100-101 S p. S41
article
286 Development and preliminary evaluation of the fluorine-18 labeled benzamido-dihydroindene derivative [18F]FBAIN as a potential radiotracer for PET imaging of the chemokine receptor CXCR5 Lindemann, Marcel

100-101 S p. S200-S201
article
287 Development and radiolabelling of fluorinated ligands targetting the Aryl hydrocarbon Receptor Vercouillie, Johnny

100-101 S p.
article
288 Development and Radiosynthesis of [11C]MODAG-005 for in vivo Imaging of alpha-synuclein Pathology Maurer, Andreas

100-101 S p.
article
289 Development and validation of [18F]FDG dual radiosynthesis on a MX cassette with a NEPTIS® module Joyard, Yoann

100-101 S p. S128
article
290 Development of a Candidate PET Radioligand for Receptor Interacting Protein 1 Kinase (RIPK1) and Evaluation in Healthy Monkey Jana, Susovan

100-101 S p.
article
291 Development of a 64Cu-labeled immuno-PET probe for imaging Sialyl Lewis X in breast cancer Kaur, Jatinder

100-101 S p. S221
article
292 Development of a dual imaging probe for bimodal PET/ two-photon NIRF imaging Jouad, Kamal

100-101 S p. S167-S168
article
293 Development of a [18F]PD-L1 radiotracer to profile cancer patient response to immunotherapy Zecca, Henry

100-101 S p. S189
article
294 Development of a highly hydrophilic 18F-tetrazine for pre-targeting approaches in PET imaging Perrio, Cecile

100-101 S p. S84
article
295 Development of a highly specific 18F-labeled benzimidazolone-based sigma-2 receptor radioligand for brain tumor imaging Huang, Henry

100-101 S p.
article
296 Development of aliphatic 18F-labeled tetrazines suitable for pretargeted PET imaging Battisti, Umberto

100-101 S p. S178-S179
article
297 Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC Hooijman, Eline

100-101 S p. S22-S23
article
298 Development of a 99mTc-NTP 15-5 kit for an early clinical trial Sophie, Levesque

100-101 S p. S145
article
299 Development of a [99mTc]Tc-PVP nanogel for controlled release of 5-FU Ges-Naranjo, Adrian

100-101 S p. S84-S85
article
300 Development of an effective electro-amalgamation technique to debulk Eu(III) from Eu(III)/Tb(III) mixtures: Towards future application in the separation of 155Tb from alpha-irradiated 153Eu Serasinghe, Madhushan

100-101 S p.
article
301 Development of a new class of Mn(II) complexes for MRI applications Boschi, Alessandra

100-101 S p. S69-S70
article
302 Development of a New 64Cu-Semicarbazone Complex: Potential Theragnostic Radiopharmaceutical for Hypoxic Tumor Alhokbany, Norah

100-101 S p.
article
303 Development of a new reagent for 18F-trifluoroethylation of secondary amine Choi, Ji Young

100-101 S p.
article
304 Development of an 18F-labeled MutT Homolog 1 (MTH1) radiotracer ([18F]WC-7-73): synthesis, radiosynthesis and evaluation Chu, Wenhua

100-101 S p.
article
305 Development of an in-house 188W/188Re generator for rhenium-188 production and radiolabelling studies Melis, Diana

100-101 S p. S38
article
306 Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging Chen, Jiahui

100-101 S p.
article
307 Development of a novel carbon-11 radiotracer for brain PET imaging of sulfonylurea receptors 1 Caillé, Fabien

100-101 S p. S33-S34
article
308 Development of a novel 68Ga-labeled benzo[h]quinoline-based FAP-targeted PET tracer: Synthesis, preclinical evaluation, and comparison with [68Ga]Ga-FAPI-04 Lin, Kuo-Shyan

100-101 S p.
article
309 Development of a novel PET ligand for imaging AMPA receptor Chen, Jiahui

100-101 S p.
article
310 Development of a novel PET tracer for imaging of γ-8 dependent transmembrane AMPA receptor regulatory protein Yu, Qingzhen

100-101 S p. S66-S68
article
311 Development of a novel reversible monoacylglycerol lipase PET tracer bearing a morpholine-3-one scaffold He, Yingfang

100-101 S p. S5-S6
article
312 Development of Approaches for High-Throughput Experimentation in Radiochemistry Webb, Eric

100-101 S p.
article
313 Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy Payne, Rachel

100-101 S p.
article
314 Development of a radiolabeled self-assembled nanoparticle as an imaging probe for CD44-expressing tumors Tanaka, Toshie

100-101 S p. S83-S84
article
315 Development of a radiotheranostics agent with albumin binder aiming to increase the therapeutic effects for At-211 labeled RGD peptide Echigo, Hiroaki

100-101 S p.
article
316 Development of a (+)RESCA-triaryl phosphine for in vitro radiolabeling using the Staudinger ligation Biti, Anisa

100-101 S p.
article
317 Development of a small-molecule CXCR3 PET radiotracer for atherosclerosis imaging in live animals Alluri, Santosh Reddy

100-101 S p. S17
article
318 Development of a stabilized GRPR antagonist for targeted cancer theranostics Abouzayed, Ayman

100-101 S p. S24
article
319 Development of a stable peptide-based PET tracer for detecting CD133-expressing cancer cells Hu, Kuan

100-101 S p. S195
article
320 Development of Astatine-211 labeling reaction using aryliodonium ylide Ogawa, Mikako

100-101 S p.
article
321 Development of automatic synthesis method for [18F]Fluoromethyl-PBR28 using two synthesizer Cho, Yong-Hyun

100-101 S p. S123
article
322 Development of bispecific theranostic ligand targeting the prostate specific membrane antigen (PSMA) and gastrin releasing peptide (GRPR) receptor Bouzioti, Danai

100-101 S p. S29-S30
article
323 Development of BODIPY-Tetrazines as Pretargeted Bimodal Fluorescent-Radioactive Tracers Herth, Matthias

100-101 S p.
article
324 Development of CD44-targeted 64Cu-labeled peptide for diagnosis of cancer stem cells Eom, Sairan

100-101 S p.
article
325 Development of C-terminal modified long-acting DOTA-JR11 analogs for optimized treatment of NETs Handula, Maryana

100-101 S p.
article
326 Development of 11C-Tucatinib as a potential HER2-targeting PET radiotracer Müller, Marius

100-101 S p. S206
article
327 Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer Seo, Hye Yeon

100-101 S p. S61
article
328 Development of discoidal phospholipid bilayer nanoparticles with styrene maleic acid copolymer for diagnosis and therapy of intractable cancers Munekane, Masayuki

100-101 S p. S83
article
329 Development of FAP targeted radiopharmaceuticals Xu, Mengxin

100-101 S p. S221
article
330 Development of [18F]Fluoromannitol, a Novel Radiopharmaceutical for Infection Imaging Simpson, Spenser

100-101 S p.
article
331 Development of [18F]fluoro-4-(vinylsulfonyl)benzene for chemoselective cysteine radiofunctionalization of peptides McDaniel, James

100-101 S p. S75-S76
article
332 Development of finely tuned liposome nanoplatform for effective macrophage targeting and depletion Choi, Tae Hyeon

100-101 S p.
article
333 Development of five Polar and Highly Reactive Tetrazines for Pretargeted Imaging Müller, Marius

100-101 S p.
article
334 Development of 18F-labeled agonist for imaging STING in the tumor microenvironment Liu, Huanhuan

100-101 S p. S19-S20
article
335 Development of 18F-Labeled tetrazines for pretargeted imaging across the blood-brain barrier Shalgunov, Vladimir

100-101 S p. S103-S104
article
336 Development of 18F-labeled tracer for noninvasive PET imaging of the STING expression in tumor microenvironment Fang, Jianyang

100-101 S p. S187-S188
article
337 Development of 18F-Labelled CXCR4-Targeted Peptide Radiopharmaceuticals Through Strain-Promoted Click Chemistry Mason, Julia

100-101 S p.
article
338 Development of freeze-dried kit for one-step expeditious preparation of [99mTc]Tc-PSMA-T4 Wojdowska, Wioletta

100-101 S p. S146
article
339 Development of freeze-dried kits for one-step expeditious formulation of [68Ga]Ga-NODAGA-JR11 Satpati, Drishty

100-101 S p. S47
article
340 Development of [68Ga]Ga-DOTA-4AH29, a radiolabeled single-domain antibody for PET imaging of FAP-α expression in cancer Berdal, Marion

100-101 S p.
article
341 Development of 68Ga-labeled riboflavin analognes for RFVTs-targeted PET imaging Chen, Yingxi

100-101 S p.
article
342 Development of gallium coordinate nonapeptides as candidates for PET imaging of neuropeptide Y1 receptors in oncology Hetsron, Amit

100-101 S p. S116
article
343 Development of 125I-labeled tetrazines Bidesi, Natasha

100-101 S p. S52-S53
article
344 Development of 123I-labelled acrylamides as radiotracer candidates for transglutaminase 2 Laube, Markus

100-101 S p. S79-S80
article
345 Development of liposome-based drug-releasing radiopharmaceutical for theranosis Kim, Jiyoon

100-101 S p.
article
346 Development of locally injectable thermo-sensitive polymer micelle using as carriers for combined radio- and chemotherapy of cancers Makino, Akira

100-101 S p.
article
347 Development of 99mTc-labeled hexavalent c(RGDfK) peptide with optimized linker structure for in vivo imaging of integrin αvβ3 Mizuno, Yuki

100-101 S p. S7-S8
article
348 Development of new aptamer-labeled radiopharmaceuticals Ozerskaya, Anastasia

100-101 S p. S43
article
349 Development of novel 64Cu-labelled antibodies for PET-CT imaging of TREM2 Shojaei, Monireh

100-101 S p. S104
article
350 Development of novel PSMA target therapeutic radiopharmaceuticals by modification with albumin binder Lee, Kyongkyu

100-101 S p. S198-S199
article
351 Development of novel sulfur-rich ligands for incorporation into mercury-197m/g radiopharmaceuticals Randhawa, Parmissa

100-101 S p. S8
article
352 Development of novel tripodal chelates for the stable chelation of theranostic radiolanthanides and actinides Carbo-Bague, Imma

100-101 S p. S148
article
353 Development of 203Pb-labeled SSTR2 radioligands for neuroendocrine tumors (NETs) imaging Chapeau, Dylan

100-101 S p. S54-S55
article
354 Development of peptide probes for imaging of CD206 positive macrophages in cancer Zhang, Bo

100-101 S p. S40
article
355 Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker Murce, Erika

100-101 S p. S48-S49
article
356 Development of (radio)fluorinated aminobenzothiazole derivatives as potential adenosine A2A receptor ligands Renk, Dana

100-101 S p. S100-S101
article
357 Development of radio-halogen-labeled PSMA-targeting ligand with high in vivo stability Yamashita, Tomoki

100-101 S p.
article
358 Development of radiolabeled polymer nano- and micron-sized carriers Muslimov, Albert

100-101 S p. S86-S87
article
359 Development of reversible monoacylglycerol lipase PET tracers with improved brain uptake He, Yingfang

100-101 S p. S36
article
360 Development of silicon fluoride acceptor (SiFA)-conjugated antibodies targeting TREM2 and Poly-GA repeats as new tracers for PET imaging of neurodegenerative diseases Shojaei, Monireh

100-101 S p. S37
article
361 Development of site-specifically labelled single-domain antibody PET probe for monitoring PD-L1 expression in cancer Chen, Yinfei

100-101 S p. S200
article
362 Development of small molecule PET-tracers targeting PD-L1 Bamminger, Karsten

100-101 S p.
article
363 Development of Solid Target Technologies for 225Ac Production with Proton Bombardment Malinconico, Mario

100-101 S p.
article
364 Development of targeted 161Tb-radiolabeled nanoparticles Lemaître, Tom

100-101 S p. S69
article
365 Development of Terbium-161 Based VLA-4 Targeted Theranostics Iweha, Ejike

100-101 S p.
article
366 Development of two [99mTc]Tc(CO)3 complexes targeting the androgen receptor Decuadra, Paula

100-101 S p. S38-S39
article
367 Development of versatile dual-modality imaging probes based on a GRPR antagonist for preoperative imaging and image-guided surgery of prostate cancer Handula, Maryana

100-101 S p. S82
article
368 Development of 89Zr-antibody-PET imaging to evaluate improved brain targeting via transferrin receptor 1: the chelator matters Wuensche, Thomas

100-101 S p. S24
article
369 Development of 89Zr-radiolabeled paclitaxel-loaded polymeric micelles for potential applications in personalized treatment of triple-negative breast cancer Sadeghzadeh, Masoud

100-101 S p. S163-S164
article
370 Diagnostic efficacy of 68Ga-DOTAGA-Duramycin for early detection of anthracycline induced cardiotoxicity in Wistar rats Gill, Gurvinder

100-101 S p. S65-S66
article
371 Differential and staging diagnosis for NSCLC patients With [68Ga] Ga-DOTA-FAPI-04 and 2-[18F]FDG PET/CT Zhou, Xin

100-101 S p. S46-S47
article
372 Diphosphine bifunctional chelators: [99mTc][TcO2(DP-PSMAt)2]+ tracers for PSMA imaging of prostate cancer Hungnes, Ingebjorg

100-101 S p. S5-S6
article
373 Direct carbon-11 isotopic radiolabeling of Domperidone from [11C]CO2: application to in vivo brain PET imaging under P-glycoprotein inhibition Caillé, Fabien

100-101 S p. S91
article
374 Direct clinical comparison of scaffold proteins [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 for imaging of HER2-positive breast cancer Tolmachev, Vladimir

100-101 S p.
article
375 Direct 11C-methylation of amines using cyclotron-produced [11C] CO2 Kealey, Steven

100-101 S p. S30
article
376 Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: antagonist versus agonist Cleeren, Frederik

100-101 S p.
article
377 Direct 18F fluorination of covalent organic framework (COF) nanosheets for PET molecular imaging Kim, Dong Wook

100-101 S p. S161-S162
article
378 Direct 18F-labeling of a dimeric RGD peptide via F-nucleophilic substitution on a phosphonate prothesis Wang, Chao

100-101 S p. S76
article
379 Discovery of [18F]F-687-TCO: An Optimized Tracer for Pretargeted PET Imaging in the CNS Cook, Brendon

100-101 S p.
article
380 Discovery, preclinical validation and early human imaging with [11C]AZ14193391 – the first blood-brain barrier permeable and subtype selective PARP1 PET radioligand Cortes Gonzalez, Miguel Angel

100-101 S p.
article
381 DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy Piron, Bérengère
2014
100-101 S p. e75-e83
nvt p.
article
382 DOTA derivatives with sulfur containing side chains as an attempt to thwart the biological instability of copper labelled radiotracers Tosato, Marianna

100-101 S p. S6-S7
article
383 DOX-PEG-198AuNPs-PEG-Tmab: multimodal radiobioconjugate for targeted radionuclide therapy of HER2-positive cancers Zelechowska-Matysiak, Kinga

100-101 S p. S165-S166
article
384 Dual labelling platform for theranostics: PSMA-targeted imaging with 99mTc and therapy with 188Re Hungnes, Ingebjorg

100-101 S p.
article
385 Dual PET imaging of microtubule destabilization and synaptic integrity in a mouse model of AD Damuka, Naresh

100-101 S p.
article
386 Dual targeting of PD-L1 and integrin avb3 with a peptide tracer Hu, Kuan

100-101 S p.
article
387 Economical radiosynthesis optimization using a multi-reaction microdroplet chip platform Rios, Alejandra

100-101 S p. S65-S66
article
388 Editorial Board
100-101 S p. i
article
389 Editorial Board
100-101 S p. ii
article
390 Editorial Board 2014
100-101 S p. IFC-
1 p.
article
391 Editorial Board
100-101 S p. i
article
392 Editorial Board
100-101 S p.
article
393 Effect of dissolution and exposure of [18F]F– on nucleophilic 18F-fluorination Mou, Zhaobiao

100-101 S p. S77-S78
article
394 Effect of (2-hydroxypropyl)-β-cyclodextrin on the solubility and in vivo behavior of the myocardial perfusion imaging agent [18F] FRho6G-DEG Inkster, James

100-101 S p. S58
article
395 Effect of metal impurities on the radiolabeling efficiency of DOTA with terbium-161 and lutetium-177: a comparative study Opsomer, Tomas

100-101 S p. S57-S58
article
396 Effects of linker and binding motif modifications on tumor uptake and distribution of 99mTc-labeled HYNIC-based PSMA-targeting SPECT tracers Lu, Kelly

100-101 S p.
article
397 Effects of Polyethylene Glycol and 8-Aminooctanoic Acid Linkers on Melanoma Uptake of [99mTc]-Tricarbonyl-NOTA-Conjugated Lactam-Cyclized Alpha-MSH Peptides Qiao, Zheng

100-101 S p.
article
398 Effects of solvents on the yield of 6-bromo-7-[11C]methylpurine Okamura, Toshimitsu

100-101 S p.
article
399 Effects of uncharged linker-modification of PSMA-617-based inhibitors on targeting properties and the pharmacokinetic profile Geis, Nicolas

100-101 S p.
article
400 Efficacy and imaging evaluation of 177Lu-labeled antibody-drug conjugates as a potential theranostic agent for HER2-positive breast cancer Kim, Heejung

100-101 S p. S104-S105
article
401 Efficient and cGMP-Compliant Manufacturing of C-11 PIB using Sep-Pak: A single cassette module approach for multiple productions Nair, Manoj

100-101 S p.
article
402 Efficient and mild copper-labelling of sensitive targeting vectors with novel triazamacrocyclic chelator Hierlmeier, Ina

100-101 S p.
article
403 Efficient cartridge-based synthesis of a novel [18F]tetrazine for large molecule labelling Rokka, Johanna

100-101 S p. S115
article
404 Efficient chelation of 134Ce/La using the macrocyclic chelators DOTA and Macropa as potential PET imaging agents Bobba, Kondapa

100-101 S p. S8-S9
article
405 Efficient 18F-fluorination for dimorpholinophosphinic fluoride Wang, Tao

100-101 S p. S79
article
406 Efficient radiosynthesis of a new folate receptor-targeting PET tracer, [18F]fluoronicotinic acid labeled folate, for imaging lung fibrosis Zhuang, Xiaoqing

100-101 S p.
article
407 EGSnrc Monte Carlo calculated dose distribution around brachytherapy sources Tuan, Hoang

100-101 S p. S175-S176
article
408 Electronic cigarette aerosol deposition of [11C]nicotine in human subjects: radiosynthesis and vaping apparatus development VanBrocklin, Henry

100-101 S p. S137-S138
article
409 Electrophilic Synthesis of 6-L-[18F]FDOPA with [18F]F2: a progress report on gas target of Cyclotron TR-Flex Kniess, Torsten

100-101 S p.
article
410 Enabling insights into the cytochrome P450 isoform specific metabolism of radiotracers by CYP overexpressing hepatoblastoma cell lines Lemm, Sandy

100-101 S p. S66-S67
article
411 Enantioselective Synthesis and Biological Evaluation of (R)- and (S)-[18F]OF-NB1 to Visualize GluN2B Subunit-Containing NMDA Receptors Rong, Jian

100-101 S p.
article
412 ENBPI ligand for 68Ga: synthesis, radiolabeling optimization, and pilot myocardial perfusion imaging with ECG-gated PET Muzzioli, Riccardo

100-101 S p. S57
article
413 Enhanced blood retention and tumor uptake of PSMA-targeting, 225Ac-labeled radioconjugates Reissig, Falco

100-101 S p. S30-S31
article
414 Epigenetic modifiers in somatostatin type 2 receptor radionuclide theranostics and early transcriptional response of mouse pheochromocytoma models Ullrich, Martin

100-101 S p. S11
article
415 Establishing the host-guest pretargeting platform with adamantane guest ligands in a xenograft model Jallinoja, Vilma

100-101 S p. S18-S19
article
416 Establishing the role of “Design of Experiments” (DoE) in the tracer development pipeline: the synthesis and evaluation of [18F] talazoparib as a case study Bowden, Gregory

100-101 S p. S78-S79
article
417 Evaluating the effect of an albumin binder for targeting melanoma tumors with 89Zr-Lumi804-Lys-pIBA-PEG4-LLP2A Fong, Cyril

100-101 S p.
article
418 Evaluating the Interplay of 89Zr-labeled Radioimmunoconjugates and Fc Receptors in Genetically Engineered Mouse Models Rodriguez, Cindy

100-101 S p.
article
419 Evaluating the in vivo distribution and stability of a 161Tb-labeled nanobody for potential cancer therapy Cassells, Irwin

100-101 S p. S50
article
420 Evaluating the potential of CCR2 for the early detection of head and neck cancer Kang, Yeona

100-101 S p.
article
421 Evaluating the radionuclide theranostic potential of a MUC13-targeting antibody in colorectal cancer Coll, Ryan

100-101 S p.
article
422 Evaluation of Actinium-225 radiolabeled cyclized alpha-melanocyte stimulating hormone (CycMSH) peptide for targeted alpha therapy Brown, Victoria

100-101 S p. S101
article
423 Evaluation of Affibody molecule Z09591 for PET imaging in fibrosis Wegrzyniak, Olivia

100-101 S p. S44
article
424 Evaluation of a multifunctional blood-brain barrier co-culture model prepared from rat primary brain endothelial cells and astrocytes: first results Schneider, Daniela

100-101 S p. S102-S103
article
425 Evaluation of an open-source 3D printed microfluidic system for the production of radiopharmaceuticals Cotton, Jonathan

100-101 S p. S123-S124
article
426 Evaluation of a Radiofluorinated Probe for Imaging Cytochrome P450 46A1 Zhao, Chunyu

100-101 S p.
article
427 Evaluation of biodistribution of a novel sugar-conjugated platinum complex labeled with 191Pt in mice Omokawa, Marina

100-101 S p.
article
428 Evaluation of 134Ce/La pair as a PET imaging surrogate for 225Ac radiotherapeutics Bobba, Kondapa

100-101 S p.
article
429 Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours Narykina, Valeria

100-101 S p. S207-S208
article
430 Evaluation of 64Cu-labeled DOTA-polymer functionalized peptides Villas Boas, Cristian Wieczorek

100-101 S p. S63-S64
article
431 Evaluation of [18F]FPy-T140 derivative PET imaging agents for CXCR4 in human cancer xenograft mouse models Phelps, Tim

100-101 S p. S20
article
432 Evaluation of 18F-Labelled Radiotracers for Imaging of Sigma-2 Receptor in the Brain of Nonhuman Primates Wenn, Mike

100-101 S p.
article
433 Evaluation of [18F]RM273 for sigma2-receptor imaging in an experimental orthotopic glioblastoma model Guendel, Daniel

100-101 S p. S184
article
434 Evaluation of in vivo behavior of Na[F-18]F as a single substance and Na[F-18]F-contained mouthwashes via intra-trachea instillation Kim, Dong Hyun

100-101 S p.
article
435 Evaluation of Iododiflunisal on amyloid-β deposition in 5xFAD Alzheimer’s disease mouse model by Positron Emission Tomography imaging. Zapero, Claudia Esposito

100-101 S p.
article
436 Evaluation of kit-based synthesis and delivery of 99mTc zoledronic acid as bone cancer imaging radiopharmaceutical Ng, Yen

100-101 S p. S208
article
437 Evaluation of 3,4,3-LI(1,2-HOPO) as a chelator for radioscandium based radiopharmaceuticals Phipps, Michael

100-101 S p. S155-S156
article
438 Evaluation of lysine modifications in the PSMA-targeting pharmacophore using positron emission tomography imaging in a preclinical model of human prostate cancer Zhang, Chengcheng

100-101 S p.
article
439 Evaluation of neuroinflammatory radiotracers in chronic traumatic encephalopathy Varlow, Cassis

100-101 S p. S109
article
440 Evaluation of 3p-C-DEPA as potential 225Ac-chelator Ahenkorah, Stephen

100-101 S p. S49
article
441 Evaluation of PET-based Human Biodistribution of a Novel Amino Acid 11C-MeLeu PET/CT Imaging in Normal Volunteers Nishii, Ryuichi

100-101 S p.
article
442 Evaluation of polyazamacrocycles functionalized with sulphur-containing pendant arms as potential chelators for theranostic silver-111 Tosato, Marianna

100-101 S p. S158
article
443 Evaluation of Pyridyl Benzofuran Derivative for Targeted Alpha Therapy of Alzheimer’s Disease Bender, Aidan

100-101 S p.
article
444 Evaluation of (R)- and (S)-18F-PF-NB1 in non-human primates for imaging the GluN2B subunits of NMDA receptor complex Wenn, Mike

100-101 S p.
article
445 Evaluation of [47Sc]Sc-HOPO toward radioscandium based radiopharmaceuticals Phipps, Michael

100-101 S p. S91-S92
article
446 Evaluation of selective Sc(III) complexes with a non-macrocyclic ligand for theranostics applications Huclier, Sandrine

100-101 S p. S56
article
447 Evaluation of tetramethylammonium salts in minimalist-like SNAr radiofluorinations Humpert, Swen

100-101 S p.
article
448 Evaluation of the binding characteristics of [18F]FBVM in non-human primates, a new radiotracer for imaging the vesicular acetylcholine transporter in vivo using positron emission tomography Serriere, Sophie

100-101 S p. S94-S95
article
449 Evaluation of the combinationally glycated albumin nanoplatform for targeting the tumor microenvironment with minimized reticuloendothelial system uptake using PET imaging Kim, JinSil

100-101 S p.
article
450 Evaluation of the effect of macrocyclic ring size on Pb(II) and Cu(II) complex stability in pyridyl containing chelators McNeil, Brooke

100-101 S p. S154
article
451 Evaluation of the effects of conjugation chemistry and different LET radionuclides in prostate cancer xenograft Strand, Joanna

100-101 S p.
article
452 Evaluation of the therapeutic effect of taurine against Alzheimer’s disease using mGluR5 PET Lee, Kyo Chul

100-101 S p. S93
article
453 Evaluation of the tumour targeting profile and characterisation of the metabolites for a novel stabilised minigastrin analogue Hörmann, Anton

100-101 S p. S194-S195
article
454 Evaluation of tin dioxide as an inorganic-based stationary phase for a potential 44Ti/44Sc generator Deri, Melissa

100-101 S p. S43
article
455 Evaluation of 44Ti/44Sc generator and 44Sc-post-processing procedures for radiopharmaceutical purposes: [44Sc]Sc-PSMA-617 and [44Sc]Sc-PSMA-I&T synthesis Larenkov, Anton

100-101 S p. S152
article
456 Examination of bifunctional chelates for efficient labeling of affibodies with 52Mn Brezovcsik, Karoly

100-101 S p. S147-S148
article
457 Examining the synergistic effect of radioimmunotherapy and immune checkpoint blockade for the treatment of metastatic melanoma Allen, Kevin

100-101 S p. S33
article
458 Expanding the radiochemist’s toolbox: carbon-11 labelled formamides and isocyanides for PET tracer synthesis Bonnemaire, Coralie

100-101 S p. S10
article
459 Experience on clinical scale formulation of ready to use [90Y] Y-hydroxyapatite microparticles utilizing 90Y produced in research reactor Chakraborty, Sudipta

100-101 S p. S140
article
460 Exploration of 99Tc pincer-type complexes interacting with small molecules Besmer, Manuel

100-101 S p. S6
article
461 Exploration of the fundamental chemistries of Ru and Pd for establishing 103Ru/103mRh Auger generator and 103Pd/103mRh in vivo generator Thery, Marie

100-101 S p. S150-S151
article
462 Exploration the fluorine chemistry to develop the [18F]FS1P1 as a promise F-18 radiotracer for imaging S1PR1 in vivo Qiu, Lin

100-101 S p. S11-S12
article
463 Exploring a Tristhione Scorpionate Ligand as a Suitable Chelator for the Theranostic Pair Antimony-119 and Antimony-117 Gé, Lorraine

100-101 S p.
article
464 Exploring bpcd ligand for theranostic radiopharmaceutical application Cazzola, Emiliano

100-101 S p. S54
article
465 Exploring new strategies for technetium radiolabeled [1,2,4,5] tetrazines Rodriguez, Gonzalo

100-101 S p. S60-S61
article
466 Exploring the chemical scope of light-activated protein conjugation and the photoradiosynthesis of 89Zr-antibodies Earley, Daniel

100-101 S p. S94
article
467 Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE Vermeulen, Koen

100-101 S p. S57
article
468 Extracorporeal clearing traps based on tetrazine ligation for pretargeted therapy and diagnostics Shalgunov, Vladimir

100-101 S p. S212
article
469 Extraction chromatographic separation of selenium and arsenic for accelerator target processing Baumeister, Jakob

100-101 S p. S92-S93
article
470 Extraction of 68Ga medical radioisotopes from Zn nitrate liquid target using atomic layer deposited microfluidics Santoso, Albert

100-101 S p.
article
471 [18F]AlF and RESCA: a novel method for radiolabeling of Affibody molecules Lechi, Francesco

100-101 S p.
article
472 [18F]ALX5406: a brain-penetrating prodrug for GlyT1-specific PET imaging Hoffmann, Chris

100-101 S p. S45
article
473 Fast, efficient, one-step purification of cyclotron produced lanthanum-135 using HDEHP-based resin and dilute hydrochloric acid Nielsen, Karin Michaelsen

100-101 S p. S18-S19
article
474 18F-Chemistry in HPLC vials - a microliter scale radiofluorination approach Laube, Markus

100-101 S p. S61
article
475 [18F]Difluorocarbene for positron emission tomography Sap, Jeroen

100-101 S p.
article
476 [18F]FEPPA PET imaging for monitoring the neuroinflammation status in a Lactacystin-induced Parkinson disease animal model. Chiu, Ching-Hung

100-101 S p.
article
477 [18F]FLUDA – A promising PET probe for the non-invasive assessment of the A2A adenosine receptor Lai, Thu Hang

100-101 S p.
article
478 18F-Fluorination Reactions and Optimizations using a Parallel Synthesis Reactor Donat, Cornelius

100-101 S p.
article
479 [18F]Fluoroform radiolabelling of the CHK1 inhibitor CCT245737 Sharma, Gitanjali

100-101 S p. S48-S49
article
480 3-[18F]Fluoro-5-hydroxy- and 3-[18F]fluorophenylserines: Preparation and initial biological evaluation Kolks, Niklas

100-101 S p.
article
481 5-[18F]Fluoro-m-tyrosine (5-[18F]FMT) - a novel promising tracer for dopaminergic imaging Vus, Stefanie

100-101 S p. S38
article
482 [18F]FS-DPA: a novel PET probe for imaging of neuroinflammation easily accessible via SuFEx click labeling Walter, Nils

100-101 S p. S110
article
483 18F-Functionalization of sulfur heteroatom frameworks via isotopic exchange in hydrous organic media Kim, Min Pyeong

100-101 S p. S37
article
484 [18F]GP1, a novel PET tracer investigated for the detection of thrombi in LVADs and for the diagnosis of valve thrombosis Hugenberg, Verena

100-101 S p.
article
485 [18F]hGTS13 for imaging of xC − transporter activity in high-grade glioma Kendrili, M. Tansel

100-101 S p.
article
486 First experiences with the SST2R-antagonist [68Ga]Ga-DATA5m-LM4 for PET imaging of tumors: preclinical comparison with [68Ga] Ga-DOTA-LM3 Kanellopoulos, Panagiotis

100-101 S p. S16-S17
article
487 First-In-Class Diagnostics Targeting Neuropeptide Y1 Receptor (Y1R): Enabling Molecular Imaging of Metastatic Breast Cancer Rahimi, Marwa Nadia

100-101 S p.
article
488 First-in-human evaluation of [99mTc]Tc-(HE)3-G3, a novel DARPin-based agent for imaging of HER2 expression in breast cancer Tolmachev, Vladimir

100-101 S p. S17-S18
article
489 First in-human studies of the glutamate transporter EAAT2 radiotracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparginate (RP-115): radiosynthesis and biodistribution evaluation Nillo, Ryan Michael

100-101 S p.
article
490 First microvolume metal-mediated synthesis of [18F]FDOPA in a microreactor Lu, Yingqing

100-101 S p. S15-S16
article
491 First time evaluation of 45Ti for radiolabeling of NOTA and DOTA chelators Milton, Stefan

100-101 S p.
article
492 F-18 labeled azaindole derivatives as PET imaging tracer for tau protein Kim, Dong Wook

100-101 S p.
article
493 18F-labeled imidazole naphthyridine derivatives as Tau imaging agents in Alzheimer’s Disease Liu, Tianqing

100-101 S p.
article
494 18F-labeled indole-based analogs with chiral 2,3-dihydroxyfluorobutoxy side chain as highly selective sigma-2 receptor probes for tumor imaging An, Xiaodan

100-101 S p. S196-S197
article
495 18F labelled albumin binding synthons enabling PET imaging and enhanced target accumulation of biomolecules Hall, Andrew

100-101 S p. S41-S42
article
496 18F-Labelled inhibitors for targeting of IDH1 mutant gliomas Neumaier, Bernd

100-101 S p.
article
497 18F-labelled probes for non-invasive assessment of the IDH genotype in diffuse glioma Cologni, Roberta

100-101 S p. S17-S18
article
498 Fluoride mediated radiosynthesis of [11C]methyl esters Neelamegam, Ramesh

100-101 S p. S73-S74
article
499 Fluorinated PET imaging probes targeting fibroblast activation protein: radiolabeling and preclinical evaluation Elvas, Filipe

100-101 S p. S40-S41
article
500 Fluorine-18 Labeling of Neutrophil Elastase Inhibitors Holm, Linus Johansson

100-101 S p.
article
501 Fluorine-mediated desilylative Carbon-11 carboxylation of acylsilanes with [11C]CO2 for the radiosynthesis of [1-11C]α-keto acids Lee, Sanghee

100-101 S p.
article
502 Fluoroquinolone dithiocarbamate rhenium and technetium-99m complexes for potential infection imaging agents Shegani, Antonio

100-101 S p. S98
article
503 18F-microbubble for PET/US imaging: conception and in vivo imaging Ariztia, Julen

100-101 S p. S166-S167
article
504 [18F]MK-7246 for Positron Emission Tomography imaging of beta cells surface marker GRP44 Cheung, Pierre

100-101 S p.
article
505 Folate receptor targeted 64Cu/ICG-labeled layered double hydroxide nanoprobe for PET/CT and NIRF imaging Lee, Kyo Chul

100-101 S p.
article
506 Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers Corlett, Alicia

100-101 S p. S16-S17
article
507 Formulation and evaluation of human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using lyophilized kits Chakraborty, Sudipta

100-101 S p. S99-S100
article
508 [18F]OXD-2314: A 4R-Tau PET Radiotracer with Improved Affinity and Brain Uptake Mason, Neale

100-101 S p.
article
509 From R&D scale to clinical trial: design of 64Cu-radiolabeled compound production for phase I process Drouin, Guillaume

100-101 S p. S141-S142
article
510 [18F]SuFEx-enabled access to an 18F-Labeled PSMA inhibitor intermediate Craig, Austin

100-101 S p. S81
article
511 [18F]Talazoparib: a novel potential PET imaging agent of PARP Muzzioli, Riccardo

100-101 S p. S7-S8
article
512 Fully automated and GMP-compliant synthesis of [18F]JK-PSMA-7 on a Trasis AllinOne module Ermert, Johannes

100-101 S p. S124
article
513 Fully automated and GMP-compliant synthesis of [18F]SynVesT-1 on a Trasis AllinOne module Ermert, Johannes

100-101 S p.
article
514 Fully automated macro- and microfluidic production and physiological animal biodistribution of [68Ga]Ga-citrate Ovdiichuk, Olga

100-101 S p. S134-S135
article
515 Fully Automated Production of [11C]ABP688, [11C]PS13, and [11C]PIB Using a TracerMaker Synthesis Module for Clinical Studies Hu, Bao

100-101 S p.
article
516 Fully automated purification of labelled antibody on PD-10 cartridges Maindron, Nicolas

100-101 S p. S131-S132
article
517 Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation Sahu, Sudeep

100-101 S p. S211-S212
article
518 Fully Automated Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan ([18F]FETrp) Jiang, Huailei

100-101 S p.
article
519 Fully automated radiosynthesis of [18F]SMBT-1 for clinical use Tago, Tetsuro

100-101 S p.
article
520 Fully automated synthesis of [11C]nicotinamide for in vivo vitamin trafficking studies Shegani, Antonio

100-101 S p. S74-S75
article
521 Functionality of a co-culture kidney model: testing the renal barrier with [18F]fluorodeoxyglucose Sihver, Wiebke

100-101 S p.
article
522 Functionalization and radiolabeling of M13 bacteriophages for PET imaging Trommer, Johanna

100-101 S p.
article
523 Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice Müller, Cristina
2014
100-101 S p. e58-e65
nvt p.
article
524 [68Ga]Ga-DOTA-C-glycosyl-RGD: synthesis, in vitro evaluation and PET imaging Mengel, Emilien

100-101 S p. S203
article
525 [68Ga]Ga-DOTA-GIP1234 for PET imaging of glucose-dependent insulinotropic polypeptide receptor (GIPR) Khalil, Amina

100-101 S p.
article
526 [68Ga]Ga-HBED-CC-exendin-4: A new GLP1R targeting radiolabeled agent for pancreas β-cell and insulinoma imaging Li, Linlin

100-101 S p. S47-S48
article
527 [68Ga]Ga-HBED-CC-FAPI derivatives with improved radiolabeling and specific tumor uptake Li, Yuying

100-101 S p.
article
528 [68Ga]Ga-NODAGA-TriGalactan a new PET-tracer for imaging of the functional liver reserve Zierke, Maximilian

100-101 S p. S65
article
529 68Ga-labeled bivalent imaging agents targeting hypoxia and PSMA in tumors Liu, Tianqing

100-101 S p.
article
530 68Ga-labeled hypoxia and PSMA dual-targeting imaging agents Liu, Tianqing

100-101 S p.
article
531 68Ga-labeled Siderophores as Specific Radiotracers for Bacterial Infections Al-Bazaz, Silav

100-101 S p.
article
532 Ga-68-labelling of quinuclidine triazole-based compound Kanasuwan, Apinan

100-101 S p. S151-S152
article
533 Gallium-68 and Copper-64 radiolabelling of hepatotropic GBVA10-9 or CPB peptide derivatives for hepatocellular carcinoma imaging Brossard, Clarisse

100-101 S p. S153
article
534 68Ga-: 99mTc-labeled LHRH analog as new potential breast cancer imaging agents Alfaya, Lucia

100-101 S p. S49
article
535 68Ga-radiolabeling of hepatitis E virus-like nanoparticles and evaluation of their ex vivo biodistribution in mice Lambidis, Elisavet

100-101 S p. S106-S107
article
536 68Ga-radiolabeling reactions is a media of protic hydroxyalkylammonium ionic liquids based on diethanolammonium salts Antuganov, Dmitrii

100-101 S p. S96-S97
article
537 68Ge/68Ga-generator: a radionuclide source or an approved drug? Kvaternik, Herbert

100-101 S p. S100
article
538 Generation of 225Ac-DOTA-rituximab SPECT image from 64Cu-DOTA-rituximab PET image using unpaired image-to-image translation Kim, Kangsan

100-101 S p.
article
539 Genipin enhances 131I-rituximab induced cell cytotoxicity in lymphoma cells Vinod, Nagarajan

100-101 S p. S218
article
540 GLP-1R targeting 68Ga-exendin-4 derivatives with lower renal retention for insulinomas and β-cell mass imaging Liu, Tianqing

100-101 S p.
article
541 Glucose-albumin nanoplatform for treating renal ischemia-reperfusion injury using reactive oxygen species scavenging properties Park, Ji Yong

100-101 S p. S163
article
542 52gMn(II)-Labelled PSMA-ligands as bimodal PET/MR imaging probes Strecker, Jonas

100-101 S p. S157-S158
article
543 GMP complaint production and quality control of a [99mTc]Tc-DTPA-GSA wet kit formulation Denholt, Charlotte

100-101 S p.
article
544 GMP compliant high-yield radiosynthesis of [18F]AlF-PSMA-11 on the IBA Synthera®+ Platform Kersemans, Ken

100-101 S p.
article
545 GMP-compliant radiosynthesis of [18F]GP1 for the detection of thrombi Hugenberg, Verena

100-101 S p. S66
article
546 GMP-level production of radiometallated immune checkpoint inhibitor nivolumab: why and how? Suchy, Mojmir

100-101 S p. S61-S62
article
547 GMP Production of Copper-64 for antibody and nanobody radiolabeling: liquid vs solid target Hrynchak, Ivanna

100-101 S p.
article
548 Halogen bond in the context of At-211 radiolabeling: the case of [211At]N-succinimidyl-3-astatobenzoate Yssartier, Thibault

100-101 S p. S159-S160
article
549 Harnessing mushroom tyrosinase and the strain-promoted oxidation-controlled 1,2-quinone cycloaddition for the synthesis of site-specifically modified 89Zr-radioimmunoconjugates Rodriguez, Cindy

100-101 S p. S21-S22
article
550 Harnessing the theranostic potential of lead radioisotopes with sulphur-containing macrocycles Tosato, Marianna

100-101 S p. S158-S159
article
551 Harnessing 89Zr-PET to study the pulmonary clearance of microplastics in mice Keinaenen, Outi

100-101 S p. S55
article
552 Head-to-head comparison of [18F]Florastamin, [18F]FDG PET/CT, and 99mTc-HDP bone scintigraphy in patients with prostate cancer Lee, Inki

100-101 S p.
article
553 Head-to-head Comparison of [18F]Florbetazine ([18F]92) and [11C] PiB in Alzheimer’s Disease Li, Yuying

100-101 S p.
article
554 HER2-specific Affibody Molecule [99mTc]Tc-ZHER2:41071: phase I clinical trial Tolmachev, Vladimir

100-101 S p.
article
555 High affinity novel CXCR4 antagonists radiolabelled with copper-67 and gallium-68 for theragnostic applications Palmer, Max

100-101 S p. S59-S60
article
556 Highly automated solid target-based production of the emerging PET isotope cobalt-55 Gé, Lorraine

100-101 S p. S170
article
557 Highly modifiable cyclopentadienyl scaffolds for the rapid development of 99mTc radioprobes Lengacher, Rapahel

100-101 S p. S90
article
558 High radiochemical yield and molar activity 52gMn from electroplated chromium Barrett, Kendall

100-101 S p.
article
559 High-sensitivity ICP-MS – an alternative for in vitro and in vivo characterization of future radiometal-based theranostic candidates Wallimann, Rahel

100-101 S p. S42-S43
article
560 High yield GMP production of [18F]FE-PE2I, a radiotracer for in vivo PET imaging the dopamine transporter Moein, Mohammad Mahdi

100-101 S p. S132-S133
article
561 High yield lead-203 cyclotron production using a thallium-205 sealed solid target for diagnostic SPECT imaging Nelson, Bryce

100-101 S p. S12
article
562 [3H]OF-NB1 and [18F]OF-NB1: novel radioligands for the preclinical assessment of GluN1/2B targeting ligands Ahmed, Hazem

100-101 S p. S95-S96
article
563 Hyaluronic acid as a potential component of radiopharmaceutical with rhenium-188 for radiosynovectomy Malysheva, Anna

100-101 S p. S41
article
564 Hypoxia targeting lutetium-177 labeled gold nanoparticles for cancer theranostic application Mittal, Sweety

100-101 S p. S162-S163
article
565 Identification of non-competitive lead peptides for the development of PET tracers targeting PD-L1 Badenhorst, Melinda

100-101 S p.
article
566 Identification of (R)-[18F]YH134 as a promising reversible MAGL PET tracer and the impact of peripheral MAGL blockade on its brain uptake Mu, Linjing

100-101 S p.
article
567 Identifying Lymph Node Metastasis in High Grade Serous Ovarian Cancer Mouse Models via ImmunoPET Imaging Mack, Kyeara

100-101 S p.
article
568 Identifying new antigens on osteosarcoma and developing novel antibodies for radioimmunotherapy Prabaharan, Chandra

100-101 S p. S209-S210
article
569 Identifying Toxicity Mechanisms Associated with f-block Radiometals through Genome-wide Toxicogenomics Pallares, Roger Molto

100-101 S p.
article
570 Imaging acute and chronic stress using 2-[18F]FDG PET Krisch, Maximilian

100-101 S p.
article
571 Imaging characterization of National Cancer Institute patient derived xenograft models Drake, Christopher

100-101 S p. S185-S186
article
572 Imaging Lung Tumor Metastasis with 89Zr-DFO-Crizanlizumab Targeting P-selectin Majekodunmi, Olufolake

100-101 S p.
article
573 Imaging of AAV-mediated gene transfer in the brain using a novel PET reporter gene tracer Stotz, Sophie

100-101 S p. S106-S107
article
574 Imaging the Sirtuin 2 (SIRT2) protein - [18F]PF-SIRT, a novel positron emission tomography radioligand candidate Read, Cai

100-101 S p.
article
575 Imidazolium Salt-Mediated Radiofluorosulfurylation to Produce 18F-labeled Aryl Fluorosulfates Kim, Jaegwan

100-101 S p.
article
576 Immune mediated inflammation and perfusion in lungs of Covid-19 patients studied with [11C]GW457427 and [15O]water: a first-in-man pilot study Antoni, Gunnar

100-101 S p. S63
article
577 ImmunoPET imaging combined with focused ultrasound to study brain pharmacokinetic of 89Zr labeled anti-PD-L1 antibodies in a syngeneic murine model of glioblastoma Chevaleyre, Céline

100-101 S p. S181-S182
article
578 Implementation and optimisation of scandium-44 and manganese-52 production at King’s College London for preclinical research Nielsen, Karin Michaelsen

100-101 S p.
article
579 Implementation of iMiDEV, a new fully automated microfluidic platform for radiopharmaceutical production Ovdiichuk, Olga

100-101 S p. S60-S61
article
580 Improved droplet-based method for isotopic exchange labeling of trifluoroborate precursors Lisova, Ksenia

100-101 S p. S64-S65
article
581 Improved Purification of Cyclotron Produced [68Ga]GaCl3 for the Radiolabeling of Dotatate Wang, Ivan

100-101 S p.
article
582 Improved Synthesis and Automation of 2-(2,6-Difluoro-4-((2-(phenylsulfonamido)ethyl)thio)phenoxy)acetamide ([11C]K2) for Imaging AMPA Receptors Witek, Jason

100-101 S p.
article
583 Improved Synthesis of 3-[18F]Fluoro-p-Hydroxyphenethylguanidine ([18F]3F-PHPG) for Clinical Evaluation of Paraganglioma, Pheochromocytoma and Related Neuroendocrine Tumors Brooks, Allen

100-101 S p.
article
584 Improved synthesis of [18F]FPATPP via Ru-mediated 18F-Fluorination Rajala, Noora

100-101 S p. S135
article
585 Improvements in separation of antimony-119 from bulk tin target using a novel dibutyl ether resin Grundmane, Aivija

100-101 S p.
article
586 Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-74 Toms, Johannes

100-101 S p.
article
587 Improving the quality of Ga radionuclides to achieve high radiolabeling yields Grundler, Pascal

100-101 S p. S45
article
588 111In/225Ac theranostic pretargeting of nodular colorectal peritoneal carcinomatosis: preclinical SPECT and autoradiography studies Chung, Sebastian

100-101 S p. S50
article
589 Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India Chakraborty, Sudipta

100-101 S p. S180-S181
article
590 Influence of albumin binders on tumor uptake of [225Ac]Ac-mcp-PSMA radioconjugates Mamat, Constantin

100-101 S p. S29
article
591 Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody Rauscher, A.
2014
100-101 S p. e66-e74
nvt p.
article
592 Influence of radiolysis on astatine-211 chemistry Ghalei, Mohammad

100-101 S p. S142
article
593 Influence of short PEG linkers on biodistribution of 225Ac-Macropa-YS5, an immunoconjugate for treating CD46 expressing cancer Bobba, Kondapa

100-101 S p. S53
article
594 Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis Vizier, Romane

100-101 S p. S120
article
595 Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis Vizier, Romane

100-101 S p. S97
article
596 Initial in vitro study of superparamagnetic iron oxide nanoparticles coated with 198AU for targeted radionuclide therapy and magnetic hyperthermia Zuk, Michal

100-101 S p. S87
article
597 Initial results of clinical phase 0 study on [68Ga]Ga-BOT5035/PET for the assessment of fibrosis activity Velikyan, Irina

100-101 S p. S68-S69
article
598 111In-labeled-anti-EphA2 antibody for SPECT imaging tracer targeting erythropoietin-producing hepatocellular receptor A2 Kimura, Hiroyuki

100-101 S p.
article
599 Inorganic ion molar absorptivity at higher energy UV wavelengths and how it affects high performance liquid chromatography results Arkins, Chase

100-101 S p.
article
600 In search of the HIV reservoir and a cure: translation of a CD30 imaging agent VanBrocklin, Henry

100-101 S p. S52
article
601 Intermediates en route to [99mTc]Tc-sestamibi: insights from HPLC and HPLC-MS do Mar Machado, Joana

100-101 S p. S36
article
602 INTERNATIONAL SCIENTIFIC PROGRAM COMMITTEE
100-101 S p.
article
603 Intramolecular Friedel-Crafts acylation of carbon-11 isocyanates enabling radiolabeling of [carbonyl-11C]DPQ Pichler, Verena

100-101 S p.
article
604 INTRODUCTION Cutler, Cathy S.

100-101 S p. S1-S2
article
605 Introduction of a polyethylene glycol linker enhances uptake of 64Cu-NOTA-conjugated lactam-cyclized alpha-MSH peptide in melanoma Qiao, Zheng

100-101 S p. S70
article
606 Introduction of terbium-161 into the clinics through its automated purification and the Good Manufacturing Practice compliant production of [161Tb]Tb-DOTA-LM3 Favaretto, Chiara

100-101 S p.
article
607 Introduction to this Abstract Supplement
100-101 S p. iii
article
608 Introduction to this Abstract Supplement
100-101 S p. ii
article
609 Investigating different chelators for a pretargeting approach with 203:212Pb- and 64:67Cu-labeled tetrazines Bauer, David

100-101 S p. S28-S29
article
610 Investigating the chemical scope of protein-ligation using photoactivatable chelates Earley, Daniel

100-101 S p. S114
article
611 Investigating the stereochemical requirements in the design of 68Ga-radiolabelled fibroblast activation protein inhibitors Flores, Jose Esteban

100-101 S p. S187
article
612 Investigating the theranostic potential of a novel MUC16-targeted antibody for ovarian cancer Mack, Kyeara

100-101 S p. S58-S59
article
613 Investigation into metabolic profile of [11C]Me-DPA Thomas, Keller

100-101 S p.
article
614 Investigation of cell surface murine CD68 as a pan-macrophage biomarker by immunoSPECT and optical imaging Roohani, Borna

100-101 S p.
article
615 Investigation of [18F]Regioisomer Formation in the Radiofluorination of Hypervalent Aryl Iodonium Salts and Ylides Zhao, Qunchao

100-101 S p.
article
616 Investigation of 68Ga/177Lu-labeled FAP-based inhibitor for diagnostic and therapeutic applications Imlimthan, Surachet

100-101 S p. S56-S57
article
617 Investigation of therapeutic effect, associated hypoxia and antioxidant signaling induced by copper-64 in colon carcinoma Niculae, Dana

100-101 S p.
article
618 Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands Müller, Cristina

100-101 S p. S27-S28
article
619 In vitro and in vivo evaluation of a 89Zr-labeled anti-TIP1 antibody Villas Boas, Cristian Wieczorek

100-101 S p. S37-S38
article
620 In vitro and in vivo evaluation of [11C]M4K2127 for PET imaging activin receptor-like kinase 2 Chasse, Melissa

100-101 S p.
article
621 In vitro and preliminary in vivo assessment of monocarboxylate transporter ligand as potential radiotracer for single photon emission computed tomography (SPECT) imaging of triple-negative breast cancer Schmitt, Sébastien

100-101 S p. S205
article
622 In-vitro binding assessment of soluble and insoluble tau protein variants with [18F]-AV1451 and [18F]-MK6240 Bansal, Aditya

100-101 S p. S99-S100
article
623 In vitro binding characteristic evaluation of radioconjugates targeting NRP-1 and: or NK1 receptor on glioma cancer model Halik, Pawel

100-101 S p. S53-S54
article
624 In vitro Characterizations of an S1PR1 Specific Radioligand [3H] CS1P1 in the Central Nervous System Jiang, Hao

100-101 S p. S30
article
625 In vitro evaluation of [18F]FDG-N3 cell uptake and intracellular SPAAC reactivity using Hoechst-DBCO Kovacs, Luciana

100-101 S p.
article
626 In vitro evaluation of 18F-fluorinated D-methionine and D-tyrosine derivatives as potential radiotracers for PET imaging of bacterial infection Betts, Helen

100-101 S p. S63-S64
article
627 In vitro evaluation of GPR17 radioligands as potential CNS stem cell imaging agents Kealey, Steven

100-101 S p. S38-S39
article
628 In Vitro Evaluation of [3H]PI-2620 and Structural Derivative in non-Alzheimer’s Tauopathies Varlow, Cassis

100-101 S p.
article
629 In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor Tawate, Megha

100-101 S p. S213
article
630 In vivo assessment of TNF-a expression by SPECT/CT antibod imaging using click chemistry in mice models of rheumatoid arthritis Yoo, Min Young

100-101 S p.
article
631 In vivo evaluation and optimization of [89Zr]Zr-DFO-NCS and [89Zr] Zr-(oxinate)4 for cell tracking Friberger, Ida

100-101 S p.
article
632 In vivo evaluation of carbon-11 labeled CRANAD-102 as a potential PET tracer for soluble species of amyloid-β species in the brain Staudt, Markus

100-101 S p. S105
article
633 In vivo evaluation of carbon-11 labeled 6,7-dimethoxy-1,2,3,4-tetrahydroinsoquinoline derivatives (11C-4-MPTHQ) for potential use as σ2R brain PET tracer Kim, Ho Young

100-101 S p. S40
article
634 In vivo evaluation of [18F]Fluoroethyl Fucose: a PET tracer for imaging and studying tumor senescence Cotton, Jonathan

100-101 S p.
article
635 In vivo PET imaging of 89Zr-labelled Natural Killer cell trafficking to solid tumour under the influence of a therapeutic antibody Pham, Truc

100-101 S p.
article
636 4-Iodophenyl-[18F]fluorosulfate as a versatile building block for Pd-catalyzed cross-coupling reactions Humpert, Swen

100-101 S p.
article
637 Isoindoline bridged [M(arene)2]+ ansa-[3]arenophanes of rhenium and 99mtechnetium Csucker, Joshua

100-101 S p. S4
article
638 Isolation of glioblastoma cancer stem cells by sedimentation field flow fractionation for the development of 3D models in supramolecular hydrogels Battu, Serge

100-101 S p. S160
article
639 Isotopic fluorine-18 radiolabelling of the anti-retroviral drug dolutegravir for pet imaging Caillé, Fabien

100-101 S p. S64
article
640 131I-urease nanomotors as potential radiotherapeutic agents for bladder cancer Gómez, María

100-101 S p.
article
641 133/135La-labeling of bleomycin and its initial radiopharmacological evaluation Nelson, Bryce

100-101 S p. S59
article
642 Lanatoside C enhances [225Ac]Ac-DOTA-rituximab induced cell cytotoxicity in lymphoma cells Nagarajan, Vinod

100-101 S p. S31
article
643 Lanatoside C enhances 131I-rituximab treatment in Raji lymphoma cells Song, Kanghyon

100-101 S p.
article
644 Large scale reliable production of [carboxyl-11C]acetate on the Synthra synthesizer. Solovyev, Dmitry

100-101 S p.
article
645 LC/MS coupled to radioactive detection for the chemical characterization of radiopharmaceuticals: identification of multiple intermediates en route to [99mTc]Tc-sestamibi do Mar Ferreira Machado, Joana

100-101 S p.
article
646 Leveraging an open science approach for PET radiotracer discovery: radiolabelling and preliminary neuroimaging of 11C-labelled activin receptor-like kinase 2 inhibitors Murrell, Emily

100-101 S p. S41
article
647 Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease. Moreno, Oscar

100-101 S p.
article
648 Long term experience in [11C]UCB-J production in Turku PET Centre Krzyczmonik, Anna

100-101 S p. S126-S127
article
649 Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors Rodman, Samuel

100-101 S p.
article
650 177Lu-, 225Ac- and 111In-labelled nonadentate bispidine ligands: synthesis, radiolabelling experiments and stability assays Kopp, Ina

100-101 S p. S11
article
651 177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry Sanders, Vanessa

100-101 S p. S25-S26
article
652 177LuIII- and 225AcIII-labelled bispidine-TATE conjugates: promising candidates for targeting neuroendocrine tumours Kubeil, Manja

100-101 S p. S68
article
653 177Lu-labeled Lys-urea-Aad-based PSMA-targeting radiotherapeutic agents with low uptake in mouse kidneys and salivary glands Kuo, Hsiou-Ting

100-101 S p. S32-S33
article
654 177Lu-labeling of on-resin clicked and cyclized HER2-targeting A9 peptide Sharma, Amit

100-101 S p. S47
article
655 [177Lu]Lu-DOTA-A9: A peptide probe targeting HER2 receptors Sharma, Amit

100-101 S p. S47
article
656 [177Lu]Lu-labeled gold nanoparticles as tumor hypoxia targeting platforms Mittal, Sweety

100-101 S p. S85-S86
article
657 [177Lu]Lu-labeled NaGdF4:Ho-Yb@m-SiO2 upconversion nanophosphors: synthesis and characterization as a potent theranostic probe Chakraborty, Sudipta

100-101 S p. S58-S59
article
658 [177Lu]Lu3+ labeling of Erlotinib analogues targeting EGFR-expressing cancers Jain, Akanksha

100-101 S p. S196
article
659 Making samrium-153 available for targeted radionuclide therapy Van de Voorde, Michiel

100-101 S p. S13
article
660 Management of legacy radioactive waste from [153Sm]Sm-lexidronam radiopharmaceutical Cusnir, Ruslan

100-101 S p. S65
article
661 Mannose Receptor (CD206) Targeting with Aluminum Fluoride-18 Labeled Mannosylated Dextran Andriana, Putri

100-101 S p.
article
662 Manual labeling, bio-distribution and administration of 177Lu-DOTATE: our long term insight at NORI Bokhari, Ayesha

100-101 S p. S122
article
663 Mass production of 64, 67Cu using accelerator-based fast neutrons Kawabata, Masako

100-101 S p.
article
664 Measurements of 186Re production cross section induced by deuterons on natW target at ARRONAX facility Guertin, Arnaud
2014
100-101 S p. e16-e18
nvt p.
article
665 Metabolic stability and tumor uptake improvements via an ABD-arm in [99mTc]Tc-DT10: first preclinical experiences in pancreatic cancer models Maina-Nock, Theodosia

100-101 S p. S17
article
666 Metabolites identification of the selective αvβ3 RGDechi chimeric peptides and their [99mTc][Tc(N)PNP]-derivatives Carpanese, Debora

100-101 S p. S44
article
667 Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery Graham, Thomas

100-101 S p. S13
article
668 Method development for centralized clinical production of 177Lu-PNT2002 Dornan, Mark

100-101 S p.
article
669 mGluR5 exploration in healthy subject by [18F]FPEB Vercouillie, Johnny

100-101 S p. S109
article
670 Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursors Zhang, Wei

100-101 S p. S88-S89
article
671 Mild condition radiolabelling and in vivo stability of nanobody constructs with terbium-161 and terbium-155 Cassells, Irwin

100-101 S p. S53-S54
article
672 Mitochondria-targeted radiocomplexes for cancer theranostics Fernandes, Célia

100-101 S p. S51-S52
article
673 Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG Schulte, Michael

100-101 S p. S135-S136
article
674 Modification of the synthesis of 18F-labeled FC-119S for our automated synthesizer Kato, Koichi

100-101 S p.
article
675 Molecular imaging and radiopharmaceutical therapy of Multiple Myeloma targeting CD46 using 89Zr and 225Ac-YS5 Wadhwa, Anju

100-101 S p.
article
676 Molecular imaging for systemic treatment decisions in patients with cancer de Vries, Elisabeth GE

100-101 S p. S1
article
677 Molecular imaging of alcoholic liver disease with phosphodiesterase (PDE) 4B targeted [18F]PF-06445974 and positron emission tomography Shao, Tuo

100-101 S p. S18
article
678 Molecular imaging of cerebral dysfunction following liver failure with cannabinoid receptor type I targeted [18F]MK-9470 and positron emission tomography Shao, Tuo

100-101 S p. S53-S54
article
679 Molecular imaging of LPS induced neuroinflammation with P2x7 targeted [18F]JNJ-64413739 by positron emission tomography Chen, Jiahui

100-101 S p. S92-S93
article
680 Molecular imaging of murine liver fibrosis with sphingosine-1-phosphate receptor 1 targeted PET ligand Shao, Tuo

100-101 S p. S55-S56
article
681 Molecular imaging of Poly (ADP-ribose) polymerase for nnalcoholic steatohepatitis detection in preclinical models Jeppesen, Troels

100-101 S p. S67-S68
article
682 Molecular imaging of PSA using DARPin scaffolds Gut, Melanie

100-101 S p. S190-S191
article
683 Molecular Radiation Resistance Signature Induced by Alpha Emitters in Metastatic Castration-resistant Prostate Cancer: Early Clinical Outcome Prediction Amghar, Mariam

100-101 S p.
article
684 99mTc-labeled PSMA SPECT CT: a cost effective alternate of PET CT in diagnostic algorithm of prostate cancer Mir, Kahkashan

100-101 S p. S204
article
685 99mTc/Re tricarbonyl biguanide complexes for cancer theranostics Xiong, Chiyi

100-101 S p. S58
article
686 [99mTc]Tc-HYNIC-EcgDf21: a defensin short analog with potential application in infection foci imaging Gretter, Mariella Terán

100-101 S p. S63
article
687 [99mTc]Tc-(η6-pharm)2]+ synthesis with direct labelling of pharmaceuticals in water Battistin, Federica

100-101 S p. S3
article
688 [99mTc]Tc-PSMA-T4 a potential radiofarmaceutical for SPECT/CT imaging of metastatic prostate cancer Wojdowska, Wioletta

100-101 S p.
article
689 Multimodal radiobioconjugate - Trastuzumab-PEG-[198Au]AuNPs-PEG-DOX for targeted radionuclide therapy of HER2-positive cancers Żelechowska-Matysiak, Kinga

100-101 S p. S86
article
690 Nanoparticles as a Radionuclide Generator System for 225Ac/213Bi Diehl, George

100-101 S p.
article
691 Nanoscale microfluidic reactions: towards near-stoichiometric carbon-11 radiolabelling for PET Edgar, Fraser

100-101 S p. S69-S70
article
692 Nanosized crystalline vehicle for targeted radionuclide therapy Lemaître, Tom

100-101 S p.
article
693 Neuroimaging of p38 MAPK with [11C]SCIO-469 Enabled by Inhibition of P-glycoprotein Chasse, Melissa

100-101 S p.
article
694 New bicyclic somatostatin receptor agonists for imaging and therapy of neuroendocrine neoplasia Franchi, Sara

100-101 S p. S66-S67
article
695 New bifunctional linchpin for tandem peptide cyclization/ radiometal incorporation Yuen, Richard

100-101 S p. S120
article
696 New CD8 imaging agents to evaluate T-cell infiltration in tumors and predict response to immunotherapy Vivier, Delphine

100-101 S p. S218-S219
article
697 New extractant-impregnated iTLC-SG paper facilitates improved TLC analysis for Cu radiolabelled peptides Svedjehed, Johan

100-101 S p. S72
article
698 New H2dedpa derivatives designed for [67/68Ga]Ga3+ and [64Cu]Cu2+ radiopharmaceutical applications de Guadalupe Jaraquemada-Pelaez, Maria

100-101 S p. S149
article
699 NEw materials for conducting radiosynthesis of 18F-compounds Maindron, Nicolas

100-101 S p. S129-S130
article
700 New phase transfer agents for fluorine 18 radiolabelling Pelletier, Rémi

100-101 S p. S16-S17
article
701 New prospects for 89Zr-immuno-PET in brain applications: Alpha-synucleinopathies Wuensche, Thomas

100-101 S p.
article
702 New way to refine direct aromatic 18F-labeling of tetrazines Andersen, Ida

100-101 S p. S76
article
703 Next generation copper complexes for efficient production of radiolabeled aromatics Hoffmann, Chris

100-101 S p.
article
704 Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives Castilla, Susana Granados

100-101 S p.
article
705 Next generation therapeutic radiopharmaceuticals targeting cholecystokinin-2 receptor positive cancers Corlett, Alicia

100-101 S p. S16
article
706 Non-invasive assessment of fibrogenesis by PET imaging using a [Al18F]RESCA-Affibody molecule targeting PDGFRβ Wegrzyniak, Olivia

100-101 S p.
article
707 Non-invasive imaging of neutrophils in acute sepsis Wilske, Frida

100-101 S p.
article
708 Noninvasive imaging of STING expression in tumor microenvironment using radioiodinated small molecule Fang, Jianyang

100-101 S p. S52
article
709 Novel bifunctional [16]aneS4-derived chelators for soft radiometals Straathof, Natan

100-101 S p. S157
article
710 Novel boron-containing amino acid analogs for tumor positron tomography and boron neutron capture therapy Chen, Junyi

100-101 S p. S181
article
711 Novel FAPI tracers with albumin-binding properties for cancer imaging and therapy Meng, Lingxin

100-101 S p. S59
article
712 Novel folate radioconjugates: optimization of functional units to improve the tissue distribution profile Becker, Anna

100-101 S p. S11-S12
article
713 Novel 68Ga-labelled nanobody for imaging of platelet-derived growth factor receptor beta Velikyan, Irina

100-101 S p.
article
714 Novel [68Ga/177Lu]Ga/Lu-AAZTA-PSMA-093 as PSMA targeting agent for diagnosis and radiotherapy Liu, Tianqing

100-101 S p.
article
715 Novel [124I]ATRi VE-821 analogue PET tracer in mouse models for prostate cancer Artschwager, Raik

100-101 S p. S177
article
716 Novel 99mTc labelled proline isocyanide derivatives as potential tumour imaging agents Ruan, Qing

100-101 S p. S43-S44
article
717 Novel pyrazolethiazole derivatives as a promising new class of ligands for alpha-synuclein fibrils and potential PET tracers for the detection of α-synucleinopathies Bonanno, Federica

100-101 S p.
article
718 Novel pyrazolethiazole derivatives as new high affinity and selective ligands for alpha-synuclein fibrils as potential PET tracers for Parkinson’s disease Bonanno, Federica

100-101 S p. S90-S91
article
719 Novel Radiofluorination via Electrophilic Activation of Alkyl Phosphates/Phosphonate Zhang, Kaiqiang

100-101 S p.
article
720 Novel Universal Agent for Cutaneous Radioactive Decontamination Craig, Austin

100-101 S p.
article
721 Occupancy of Glucagon Like Peptide-1 receptor by Tirzepatide and SAR441255 measured with [68Ga]Ga-DO3A-exendin-4/PET in vivo. Khalil, Amina

100-101 S p.
article
722 O-[18F]fluoroalkylation of phenol derivatives with [18F] epifluorohydrin in the presence of t-Bu-P4 base Fujinaga, Masayuki

100-101 S p.
article
723 One batch multiple clinical doses production of [18F]FET with an home-built automated multipurpose [18F]-radiosynthesis module Zheng, Qi-Huang

100-101 S p. S139-S140
article
724 ‘One-fits-both’: searching a ligand for the chelation of theranostic mercury and silver radioisotopes Tosato, Marianna

100-101 S p. S11-S12
article
725 One-step automated radiosynthesis of N-succinimidyl-4-[18F]Fluorobenzoate ([18F]SFB) Nagachinta, Surasa

100-101 S p. S117
article
726 On the regiochemistry of the synthesis of 18F-labelled difluoroarenes via the copper mediated substitution of tin derivatives Stouse, Adrien

100-101 S p. S36-S37
article
727 Open-shell nanosensitizers for glutathione-responsive sonodynamic therapy of breast cancer Ni, Dalong

100-101 S p. S26-S27
article
728 Operation of a thorium-229/actinium-225 generator at Canadian Nuclear Laboratories Perron, Randy

100-101 S p.
article
729 Optical Imaging with a biological vector for diagnosis of oncologic diseases Thakur, Mathew

100-101 S p.
article
730 Optimal ‘hardness’ of non-macrocyclic chelators for [203Pb]Pb2+ radiopharmaceutical applications Ingham, Aidan

100-101 S p. S25
article
731 Optimisation of the radiosynthesis of [18F]FDG on MX cassette: application to the dual batch process on NEPTIS® platform Maindron, Nicolas

100-101 S p. S128-S129
article
732 Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with 44m/44Sc and experimental evidence of the feasibility of an in vivo PET generator Huclier-Markai, S.
2014
100-101 S p. e36-e43
nvt p.
article
733 Optimization of reaction volumes and reagent amounts for the preparation of various 18F-radiolabelled radiotracers Maindron, Nicolas

100-101 S p. S130
article
734 Optimization of the automated radiosynthesis of an 18F-labeled tetrahydroquinoline derivative for brain HDAC6 imaging Tago, Tetsuro

100-101 S p.
article
735 Optimization of the routine production of the ketone body tracer (R)-[11C]3-hydroxybutyric acid Nielsen, Erik

100-101 S p. S23-S24
article
736 Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [68Ga]Ga-ABY-025 tracer Jussing, Emma

100-101 S p.
article
737 Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer Le Roux, Alexandre

100-101 S p. S3-S4
article
738 Optimized QMA-elution enables direct aliphatic 18F-fluorination of highly reactive tetrazines for pretargeted imaging Bratteby, Klas

100-101 S p. S79-S80
article
739 Optimized quality control analysis for GMP production of the clinical 18F-labelled NET tracer [18F]SiTATE Kerminen, Edla

100-101 S p.
article
740 Optimized Radiosynthesis of Racemic 2-[18F]Fluoropropionic Acid for PET Imaging of Incipient Heart Failure Singh, Pradeep

100-101 S p.
article
741 Optimized synthesis of tri(hydroxypyridinone)-tetrazine and 68Ga-radiolabeling for bioorthogonal chemistry Centanni, Alessia

100-101 S p. S50-S51
article
742 Optimized synthesis of tris(hydroxypyridinone)-tetrazine and 68Ga radiolabeling for bioorthogonal chemistry Centanni, Alessia

100-101 S p. S148-S149
article
743 Optimizing 203Pb cyclotron production and availability: The ideal SPECT imaging theranostic partner for 212Pb targeted alpha therapy Nelson, Bryce

100-101 S p.
article
744 Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synuclein Bratteby, Klas

100-101 S p. S87-S88
article
745 Organometallic cancer theranostics: incorporation of Re and 99mTc into the small molecule kinase inhibitor Opaganib® Lengacher, Raphael

100-101 S p. S55-S56
article
746 Organotin derivatives as versatile precursors for the radioiodination and radiofluorination of 1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid (TIC(OH)) analogues Maisonial-Besset, Aurélie

100-101 S p. S17
article
747 Original 18F-thiol prosthetic group for labeling of dehydroalanine-containing biologics Richard, Mylène

100-101 S p. S75
article
748 Our experiences working with the development module Neptis x Seed Ohlsson, Tomas

100-101 S p.
article
749 [15O]Water – a timeless challenge under GMP Ross, Tobias

100-101 S p.
article
750 Palladium-mediated synthesis of 11C-labelled acyl amidines and their cyclization to 11C-labelled 1,2,4-oxadiazoles from aryl halides and amidines Roslin, Sara

100-101 S p.
article
751 PAM and FUS-assisted local AAV gene delivery into the brain of Alzheimer’s disease murine models assessed by quantitative PET reporter gene Ajenjo, Javier

100-101 S p.
article
752 3p-C-NETA-TATE: a versatile somatostatin analogue for Al18F-labeled and therapeutic SSTR2 targeting radiopharmaceuticals Ahenkorah, Stephen

100-101 S p. S10-S11
article
753 PEGylated liposome encapsulating nido-carborane: boron neutron capture therapy (BNCT) and in vivo trafficking study in animal models Kim, Kyungwon

100-101 S p. S15
article
754 PEGylation modulation of peptides promotes PET detection of cancers Hu, Kuan

100-101 S p. S88-S89
article
755 Peptide turn mimics formed by the coordination of Tc:Re-tricarbonyl Oza, Dhvani

100-101 S p. S5
article
756 Perfluoroaryl azide staudinger reaction combined with sulfur [18F]Fluoride exchange click chemistry for live cell radiolabeling Biti, Anisa

100-101 S p. S78
article
757 Performance assessment of quantitative preclinical SPECT imaging with 155Tb and 161Tb Koniar, Helena

100-101 S p.
article
758 Performance evaluation of the IRIS XL-220 PET/CT system, a new camera dedicated to non-human primates Boisson, Frédéric

100-101 S p. S173
article
759 PET/CT Imaging of avb6 Integrin to Monitor Radiation-Induced Pulmonary Fibrosis Villas Boas, Cristian Wieczorek

100-101 S p.
article
760 PET/CT Imaging Reveals Enhanced Spleen Uptake After Humanization of an Annexin A1 Targeting Antibody Houson, Hailey

100-101 S p.
article
761 PET imaging and biological uptake of toxic diesel particulate matter in mice via different routes of exposure Park, Jung Eun

100-101 S p.
article
762 PET Imaging of [68Ga]Ga-NOTA-insulin in Alzheimer’s disease mouse model Pandey, Mukesh

100-101 S p.
article
763 PET imaging of lung inflammation in pig by neutrophil elastase inhibitor [11C]GW457427 Eriksson, Olof

100-101 S p. S65
article
764 PET imaging of neurotensin receptor-positive tumors with 68Ga-labeled antagonists: “the chelate makes again the difference” Renard, Emma

100-101 S p. S6-S7
article
765 PET Imaging of Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68 Houson, Hailey

100-101 S p.
article
766 PET imaging of PD-L1 expression in brain tumours Sharma, Gitanjali

100-101 S p.
article
767 PET imaging of PD-L1 overexpressing tumors with a 68Ga labeled D-dodecapeptide Hu, Kuan

100-101 S p. S2
article
768 Pharmacokinetic, dosimetry and antitumor efficacy of 64Cu/NOTA-terpyridine platinum, a potential radio-chemo-theranostic agent Khosravifarsani, Meysam

100-101 S p. S57
article
769 Pharmacokinetic preclinical evaluation of radioligation strategies impact on antibody fragment targeting PD-L1 Truillet, Charles

100-101 S p. S118-S119
article
770 Pharmacokinetics, Dosimetry and Therapeutic efficacy of [225Ac] Ac-DOTA-TDA-Lipiodol® in a murine cancer model: The importance of considering the actinium-225 in vivo generated decay daughters for accurate treatment dosing Josefsson, Anders

100-101 S p.
article
771 Phase I trial for SPECT imaging of GRPR expression in malignant tumors using [99mTc]Tc-maSSS-PEG2-RM26 prepared using one-pot labeling kit Orlova, Anna

100-101 S p.
article
772 Photoaffinity labeling for the site-specific bioconjugation of 89Zr-labeled radioimmunoconjugates Delaney, Samantha

100-101 S p. S17-S18
article
773 PhotoDynamicTherapy by Cerenkov luminescence induct by Gallium-68 on AGuIX@Terbium-porphyrin ultrasmall nanoparticle Collet, Charlotte

100-101 S p. S161
article
774 Photoredox-assisted 18F-radiodeoxyfluorination of diaryl ethers favors the more electron-rich aryl group Jiang, Meijuan

100-101 S p.
article
775 Polyacrylamide gel electrophoresis based method for investigation of metabolic stability of [68Ga]Ga-BOT5035 in vitro and in vivo Velikyan, Irina

100-101 S p.
article
776 Practical considerations on the production of copper radioisotopes from enriched liquid targets: a five years’ experience Fonseca, Alexandra

100-101 S p. S44-S45
article
777 Preclinical assessment of nanoparticles conjugated with 64Cu-DOTA-PEG-BBN targeting gastrin-releasing peptide receptors Niculae, Dana

100-101 S p. S14-S15
article
778 Preclinical characterization of [18F]FB-labeled single-domain antibodies for PET imaging of FAP-α or Folate-α overexpression in cancer Dierick, Herlinde

100-101 S p.
article
779 Preclinical development of CD133 targeted immunoPET probes Wyszatko, Kevin

100-101 S p. S19-S20
article
780 Preclinical development of [89Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas Alvarez, Natalia Herrero

100-101 S p. S192-S193
article
781 Preclinical evaluation of antisense-oligonucleotide (ASO) brain distribution using PET and SPECT imaging post intrathecal injection Rafidi, Hanine

100-101 S p.
article
782 Preclinical evaluation of ePSMA-DM1: a PSMA-targeting theranostic small molecule drug conjugate Seimbille, Yann

100-101 S p.
article
783 Preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter Vercouillie, Johnny

100-101 S p. S110
article
784 Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation Holzleitner, Nadine

100-101 S p.
article
785 Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide El Fakiri, Mohamed

100-101 S p.
article
786 Preclinical evaluation of GRPR-antagonists based on a highly stable variant for imaging of prostate cancer Kanellopoulos, Panagiotis

100-101 S p.
article
787 Preclinical evaluation of [111In]In-labeled GRPR-targeting DB15 mimics for potential theranostic use in prostate cancer Kanellopoulos, Panagiotis

100-101 S p.
article
788 Pre-clinical evaluation of lead-203 as an imaging surrogate for lead-212 radiopharmaceuticals Cagle, Brianna

100-101 S p. S22-S23
article
789 Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors Wharton, Luke

100-101 S p.
article
790 Preclinical evaluation of [89Zr]Zr-DFO*-sacituzumab, a PET tracer for imaging of whole body TROP-2 expression as a potential selection tool for treatment with TROP-2 antibody drug conjugates (ADC) Bratteby, Klas

100-101 S p.
article
791 Preclinical evaluation of [89Zr]Zr-ramucirumab: the monoclonal antibody for imaging of VEGFR2 positive tumors Novy, Zbynek

100-101 S p. S56-S57
article
792 Preclinical PET imaging of GSK-3 in pancreatic cancer Boyle, Amanda

100-101 S p. S19
article
793 Preclinical validation of [18F]-FB-(Anti Human PD-L1) nanobody for PET imaging Dierick, Herlinde

100-101 S p. S141
article
794 Preface of the Workshop on Innovative Personalized Radioimmunotherapy (WIPR 2013) Huclier, Sandrine
2014
100-101 S p. e1-e6
nvt p.
article
795 Preliminary evaluation of a novel carbon-11 labeled brain-penetrant EGFR-TKI radiotracer for brain cancer imaging Guttormsen, Yngve

100-101 S p. S42-S43
article
796 Preliminary evaluation of 124I labeled virus receptor binding domain Li, Dan

100-101 S p. S50-S51
article
797 Preparation and cGMP-compliant production of the bombesin analogue [68Ga]Ga-NOTA-RM26 for first-in-human clinical study of gastrin-releasing peptide receptor expression in prostate cancer Jussing, Emma

100-101 S p. S197-S198
article
798 Preparation and characterization and radiolabelling of multivalent ligands towards positron emission tomography imaging of oligomeric forms of misfolded proteins involved in neurodegenerative diseases Thompson, Stephen

100-101 S p. S107-S108
article
799 Preparation and evaluation of an ADAM8-targeted 111In-labeled antibody for the detection of early pancreatic cancer Fuchigami, Takeshi

100-101 S p.
article
800 Preparation and multimodality imaging study of 64Cu labeled organic nanoparticles targeting fibroblasts activation protein (FAP) in U87MG model Wen, Li

100-101 S p. S164-S165
article
801 Preparation and preclinical evaluation of novel 18F-labeled FAP ligands Hoffmann, Chris

100-101 S p.
article
802 Preparation of a 18F-labeled COX-2 inhibitor via [18F]SuFEx reaction Craig, Austin

100-101 S p. S80
article
803 Preparation of a representative non-radioactive sterility sample during the preparation of a long-lived radiopharmaceutical Stuijt, Jeffrey

100-101 S p.
article
804 Preparation of 211At-labeled aromatic compounds from thioarylprecursors Maingueneau, Clémence

100-101 S p. S43-S44
article
805 Preparation of electrodeposited UO2 target for fission-99Mo production Shen, Yijia

100-101 S p. S103-S104
article
806 Preparation of 5-[18F],7-difluoro- and 5,7-[18F]difluorotryptophans Kolks, Niklas

100-101 S p. S35
article
807 Preparation of Infective Endocarditis Models and PET Imaging Studies Using [18F]FDG and Other Radiotracers Lim, Jeong Eun

100-101 S p.
article
808 Preparation of radiofluorinated tyrosine derivatives via 18F-SuFEx chemistry and their in vivo evaluation Walter, Nils

100-101 S p. S76
article
809 Preparation of radiolabeled sulfamoyl fluorides by SuFEx 18F/19F isotopic exchange and assessment of their in vivo stability Hoffmann, Chris

100-101 S p.
article
810 Preparation of titanium complexes for in vivo PET imaging Strecker, Jonas

100-101 S p. S8-S9
article
811 Preparing a 18F-labeled modification of a PD-L1 inhibitor via [18F] SuFEx reaction Craig, Austin

100-101 S p. S80-S81
article
812 Preparing Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist [18F]Ubrogepant to Enable Biodistribution Studies in Non-Human Primate Fan, Kuo-Hsien

100-101 S p.
article
813 Pressed chromium/sodium fluoride target for cyclotron production of manganese-52 Nielsen, Karin Michaelsen

100-101 S p. S102-S103
article
814 Pretargeted Alpha Therapy of Disseminated Cancer - Combining Click Chemistry and Astatine-211 Timperanza, Chiara

100-101 S p.
article
815 Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids Auchynnikava, Tatsiana

100-101 S p.
article
816 Process validation of Ga-68 labelled FAPI-46 at HUS Diagnostic Center Koivula, Teija

100-101 S p. S143-S144
article
817 Production and application of the 203Pb/212Pb theranostic pair at TRIUMF McNeil, Brooke

100-101 S p. S95-S96
article
818 Production and characterization of high purity radioscandium isotopes, 43,47Sc, of clinical interest from proton bombardment on enriched [46,50Ti]TiO2 targets Cingoranelli, Shelbie

100-101 S p. S49-S50
article
819 Production and purification of the Auger emitters Lanthanum-135 and Erbium-165 Pedersen, Kristina

100-101 S p.
article
820 Production and radiochemical separation of terbium-155 from enriched gadolinium target material and its preliminary application in SPECT imaging Favaretto, Chiara

100-101 S p. S50-S51
article
821 Production of clinical amounts GMP compliant zirconium-89 from cyclotron liquid targets: towards global availability of 89Zr-based radiopharmaceuticals Silva, Magda

100-101 S p.
article
822 Production of emerging theranostic radionuclides at TRIUMF Radchenko, Valery

100-101 S p. S172
article
823 Production of [18F]fluoromannitol facilitated by solid phase flow chemistry toward PET Imaging of bacterial Infections Jouad, Kamal

100-101 S p.
article
824 Production of high-specific-activity erbium-169, ytterbium-175 and thulium-167 Talip, Zeynep

100-101 S p. S13-S14
article
825 Production of 117mSn using Sb alloy targetry Baumeister, Jakob

100-101 S p. S23-S24
article
826 Production of PET Radiopharmaceutical for Cholinergic Imaging Latter, Melissa

100-101 S p.
article
827 Production of Strontium-85 via deuteron-induced nuclear reactions on natural rubidium Tanzey, Sean

100-101 S p. S22
article
828 Production of 89Zr from cyclotron using yttrium foil: a new target design Pandey, Mukesh

100-101 S p. S103
article
829 Promising potential 68Ga-labeled small-molecular tracers for immune checkpoint ligand PD-L1 expression in tumor Lu, Jie

100-101 S p. S199
article
830 Proof-of-concept optimization of copper-mediated radiosynthesis of [18F]FBnTP using a novel automated robotic high-throughput droplet radiochemistry system Jones, Jason

100-101 S p.
article
831 Proof of principle: [18F]AlF radiolabelling using a droplet microreactor Lu, Yingqing

100-101 S p.
article
832 Protein 18F radiolabelling by Snap-Tag: synthesis and radiofluorination of O6-benzylguanine derivatives Ariztia, Julen

100-101 S p. S77
article
833 Quality assessment of cyclotron-produced 67Cu Brühlmann, Santiago

100-101 S p. S42
article
834 Quality control of 99mTc-radiopharmaceuticals: assessing our clinical practice do Mar Ferreira Machado, Joana

100-101 S p.
article
835 Quantification of radiotracer accumulation in a dynamic column-based 3D cell culture Pichler, Verena

100-101 S p. S14
article
836 Quantitation of a CB1R tracer [18F]FPATPP with radioLC/MS/MS Lahdenpohja, Salla

100-101 S p. S174
article
837 Quantitative Evaluation of a Novel PET Radioligand for the Monoacylglycerol Lipase (MAGL) in Non-Human Primates Gu, Jiwei

100-101 S p.
article
838 Quick determination of 90SR/90Y for application in nuclear medicine by counting gross-beta activity Tuan, Hoang

100-101 S p. S172
article
839 Radiation-induced DNA Damage and Repair in Targeted Radionuclide Therapies in Comparison to External Beam Radiation Winter, Ruth

100-101 S p.
article
840 Radioactive Isotopes for Cancer Radiotherapy Hoehr, Cornelia

100-101 S p. S2
article
841 Radiobioconjugates of 193m,195mPt nanoparticles for combined “chemo-Auger electron” therapy of hepatocellular carcinoma (HCC) and HER2+ breast and ovarian cancers Wawrowicz, Kamil

100-101 S p. S48
article
842 Radiochemical aspects of synthesis and analysis of [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T single-dose preparations Larenkov, Anton

100-101 S p. S152
article
843 Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3 Tawate, Megha

100-101 S p. S146
article
844 Radiochemical synthesis and automation of an 18F-radiolabelled oligonucleotide for PET imaging of miRNA-223 in relation to neuroinflammation Zientek, Simon

100-101 S p. S113-S114
article
845 Radiochemical synthesis of [18F]Fluoroanilines via flow reduction Wilde, Justin

100-101 S p. S139
article
846 Radiofluorination of Ruppert-Prakash reagent (Me3SiC[18F]F3) for syntheses of 18F-trifluoromethylated compounds Pees, Anna

100-101 S p. S23
article
847 Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism Wright, Jay

100-101 S p.
article
848 Radioiodinated and astatinated NHC rhodium complexes: Synthesis Rajerison, Holisoa
2014
100-101 S p. e23-e29
nvt p.
article
849 Radioiodination of galacto-bombesin using a residualizing prosthetic agent for imaging of gastrin-releasing peptide receptor Lim, Hwisoo

100-101 S p.
article
850 Radioiodination of prosthetic groups for disulphide rebridging Krzyczmonik, Anna

100-101 S p.
article
851 Radioisotope-loaded microbubbles for cancer imaging and therapy Gower-Fry, Kaley

100-101 S p. S149-S150
article
852 Radiolabeled chimeric interlukine-1 (IL-1) receptor antagonist for imaging tumor microenvironment of colorectal cancer Liu, Zhonglin

100-101 S p. S202
article
853 Radiolabeled gold nanoseeds containing substance P peptides: synthesis, characterization and evaluation in glioblastoma cells Raposinho, Paula

100-101 S p. S30
article
854 Radiolabeled Microbubbles as a Theranostic Modality in Nuclear Medicine Gower-Fry, Kaley

100-101 S p.
article
855 Radiolabeled peptidomimetic inhibitors of the VEGF:NRP-1 complex as diagnostic: therapeutic radiopharmaceuticals Masłowska, Katarzyna

100-101 S p. S56
article
856 Radiolabeled supramolecular coordination complexes targeted to somatostatin receptors Deiser, Sandra

100-101 S p. S73-S74
article
857 Radiolabeling and biological evaluation of functionalized spherical nucleic acids Auchynnikava, Tatsiana

100-101 S p. S39-S40
article
858 Radiolabeling and evaluation of cyclohexyl (5-(2-acetamidobenzo[d]thiazol-6-yl)-2-methylpyridin-3-yl) carbamate (PK68), a potent inhibitor for receptor interacting protein 1 kinase (RIPK1) Kumata, Katsushi

100-101 S p. S113
article
859 Radiolabeling and evaluation of 68Ga-DOTA-F56 peptide targeting vascular endothelial growth factor receptor Zhang, Qian

100-101 S p. S222
article
860 Radiolabeling and in vitro studies of scandium-44 with HOPO chelator for PET imaging Gajecki, Leah

100-101 S p. S52-S53
article
861 Radiolabeling and preclinical evaluation of a novel PET ligand for imaging phosphodiesterase (PDE) 4B Chen, Jiahui

100-101 S p. S91-S92
article
862 Radiolabeling of HER2 targeting single domain antibody with Tc-99m and Re-188 Altunay, Betül

100-101 S p. S6
article
863 Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice Frindel, Mathieu
2014
100-101 S p. e49-e57
nvt p.
article
864 Radiolabeling of hyaluronan and hyaluronan-α vβ6-Binding Peptide for PET imaging Zhang, Hua

100-101 S p.
article
865 Radiolabeling of small molecules and peptides with therapeutic radionuclide Cu-67 for theranostic applications Pike, Susan

100-101 S p. S156
article
866 Radiolabeling of two different precursors of m-[211At] astatobenzylguanidine using 211At purified by wet extraction. Kang, Choong Mo

100-101 S p.
article
867 Radiolabelling of biomolecules with an original exo-maleimide prosthetic group Richard, Mylène

100-101 S p. S117-S118
article
868 Radiolabelling of DOTA-Kisspeptin with gallium-68 and lutetium-177 Kleynhans, Janke

100-101 S p. S143
article
869 Radiolabelling of small extracellular vesicles with gallium-68 Kunnas, Jonne

100-101 S p.
article
870 Radiometabolite structural confirmation of [11C]CS1P1, a promising radiotracer for imaging neuroinflammation of patients with Multiple Sclerosis Qiu, Lin

100-101 S p.
article
871 Radionuclide therapy with the second-generation Affibody molecule [188Re]Re-Z41071 improves survival in mice bearing human HER2-expressing xenografts Liu, Yongsheng

100-101 S p. S27
article
872 Radiopharmaceutical preparation and quality control of 225Ac-DOTAGA-IAC for tumor targeted alpha therapy (TAT) Pandey, Somit

100-101 S p. S144-S145
article
873 Radiopharmaceutical production and stability studies of 18F-rhPSMA-7.3 injection on a Siemens Explora GN Synthesis Module Haka, Michael

100-101 S p.
article
874 Radiopharmacological comparison of an Al18F- and 68Ga-labeled somatostatin agonist and antagonist in 2D and 3D models of BON-SSTR2 cells Sihver, Wiebke

100-101 S p.
article
875 Radiosynthesis and analysis of (S)-4-(3-[18F]fluoropropyl)-L-glutamic acid Brown, Gavin

100-101 S p.
article
876 Radiosynthesis and biological evaluation of a nicotinic acid hydroxamate derivative as a radioligand for HDAC6 PET imaging Tago, Tetsuro

100-101 S p. S107
article
877 Radiosynthesis and biological evaluation of 10-[11C] methoxy-berberine as a novel PET tracer for visualizing berberine metabolism and distribution in mice Zhang, Xiaojun

100-101 S p. S69
article
878 Radiosynthesis and biological evaluation of [18F]AG-120 as imaging agent for the detection of the mutant isocitrate dehydrogenase 1 in glioma by PET Toussaint, Magali

100-101 S p.
article
879 Radiosynthesis and biological evaluation of [18F]CooP: a brain-homing peptide for imaging glioblastomas using positron emission tomography Dillemuth, Pyry

100-101 S p. S18-S19
article
880 Radiosynthesis and biological evaluation of [18F]R91150, a selective 5-HT2A receptor antagonist for PET imaging Willmann, Michael

100-101 S p. S35-S36
article
881 Radiosynthesis and biological investigation of an 18F-labeled triazolopyridopyrazine-based inhibitor for imaging of the phosphodiesterase 2A enzyme (PDE2A) in brain Wenzel, Barbara

100-101 S p. S111
article
882 Radiosynthesis and Characterisation of [18F]antagomir-223: A Potential PET Radiotracer for Imaging Neuroinflammation Zientek, Simon

100-101 S p.
article
883 Radiosynthesis and evaluation of a new PET tracer for imaging of leucine-rich repeat kinase 2 Mori, Wakana

100-101 S p.
article
884 Radiosynthesis and Evaluation of a Novel 18F-Labeled Tracer for PET Imaging of Glycogen Synthase Kinase-3 (GSK-3) Li, Yinlong

100-101 S p.
article
885 Radiosynthesis and evaluation of [18F]SNFT-1 for imaging early tau deposition Harada, Ryuichi

100-101 S p.
article
886 Radiosynthesis and first preclinical evaluation of an 18F-radiolabelled ligand for cancer stem cells non-invasive PET imaging Toussaint, Magali

100-101 S p. S216
article
887 Radiosynthesis and in vitro comparison of [225Ac]Ac-DOTA-dhPzPEG4- and [225Ac]Ac-macropa-tzPEG3Sq-conjugated ch806, a tumour-specific anti-EGFR antibody, and preclinical evaluation in a murine glioma model Wichmann, Christian

100-101 S p. S14-S15
article
888 Radiosynthesis and in vitro evaluation of [99mTc]-labeled hyaluronic acid derivatives Sarasamkan, Jiradanai

100-101 S p. S156-S157
article
889 Radiosynthesis and preclinical biodistribution of a carbon-11-labelled STING agonist Hill, James

100-101 S p. S193
article
890 Radiosynthesis and preclinical evaluation of [11C]mitragynine isotopomers in rodents Seo, Jinpyo

100-101 S p.
article
891 Radiosynthesis and Preliminary Evaluation of a 18F-Labeled PET Tracer Targeting CYP1B1 Li, Yuying

100-101 S p.
article
892 Radiosynthesis and preliminary evaluation of an 18F-labeled diarylpyrrole-based PET tracer targeting COX-2 Li, Yuying

100-101 S p.
article
893 Radiosynthesis and preliminary evaluation of a novel PET probe for neuronal complement C3 activation imagingRadiosynthesis and preliminary evaluation of a novel PET probe for neuronal complement C3 activation imaging Suzuki, Chie

100-101 S p.
article
894 Radiosynthesis, in vitro and in vivo evaluation of [18F]Z-3540 for imaging 4R-tauopathies Lindberg, Anton

100-101 S p.
article
895 Radiosynthesis, in vitro and in vivo evaluations of [3H]/[18F]CBD-2115 as first in class radiotracers for imaging 4R-tauopathies Lindberg, Anton

100-101 S p. S9-S10
article
896 Radiosynthesis of [11C]EHT1610, a potential radioligand for quantification of cerebral DYRK1A by PET imaging POUTREL, Pauline

100-101 S p. S95
article
897 Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 dependent transmembrane AMPA receptor regulatory protein Yu, Qingzhen

100-101 S p. S97-S98
article
898 Radiosynthesis of D-[1-11C]alanine and D-[3-11C]alanine isotopomers Rabbitt, Sarah

100-101 S p.
article
899 Radiosynthesis of [18F]AmBF3-Tyr3-Octreotides with Tetrazine Ligation Based on the Inverse Electron-Demand Diels–Alder Reaction: Rapid, Catalyst-free and Mild Conversion of 1,4-Dihydropyridazines to Pyridazines Otaru, Sofia

100-101 S p.
article
900 Radiosynthesis of [18F]2- and [18F]4-fluoro[1,3]-pyrimidines Kumar, Dileep

100-101 S p. S82-S83
article
901 Radiosynthesis of [18F]fluoroadenosine derivative : a new imaging agent for HSP70 Ghosh, Pradip

100-101 S p. S72-S73
article
902 Radiosynthesis of [18F]FP-CIT using azetidinium salt precursor and evaluation of radiochemical purity and stability Kim, Dong Hyun

100-101 S p. S126
article
903 Radiosynthesis of 18F labelled D-amino acid tracers and their use for bacteria imaging Sorlin, Alexandre

100-101 S p. S68
article
904 Radiosynthesis of [18F]talazoparib and biodistribution study in PC3 prostate tumor mice Zhou, Dong

100-101 S p. S45
article
905 Radiosynthesis of [18F]VU6010572 as a PET radiotracer for imaging metabotropic glutamate receptor 3 (mGluR3) Rong, Jian

100-101 S p. S100-S101
article
906 Radiosynthesis of new PET tracer targeting macrophage mannose receptor Andriana, Putri

100-101 S p. S62-S63
article
907 Radiosynthesis of novel PET tracers for α-synuclein imaging Hoang, Anh

100-101 S p. S96
article
908 Rapid and Efficient Syntheses of [11C]Trifluoroethoxy Heteroarenes with a Novel 11C-Labeling Synthon, [11C]CF3CH2OK Zhao, Qunchao

100-101 S p.
article
909 Rapid and precise quantification of radiochemical yields by analytical HPLC with post column injection Humpert, Swen

100-101 S p.
article
910 Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform Lu, Yingqing

100-101 S p.
article
911 223Ra-radiolabeling: predicting stability using molecular modelling Mohaman, Hamissou

100-101 S p. S154-S155
article
912 64 reactions in an hour using an automated, robotic high-throughput radiochemistry optimization platform Jones, Jason

100-101 S p. S59
article
913 Real-time tracking of micro- and nanoplastics in mice after pulmonary exposure Keinänen, Outi

100-101 S p.
article
914 Recovery and purification of Zn-68 after cyclotron irradiation and Ga-68 recovery Dunling, Eleanor

100-101 S p. S43-S44
article
915 Reducing protodeboronation using a novel boronic ester in the late-stage copper-mediated radiofluorination Jaworski, Carolin

100-101 S p. S46-S47
article
916 Reducing the renal retention of 111In-labelled fibronectin-binding peptides through brush border-enzyme sensitive cleavable linkers Valpreda, Giulia

100-101 S p. S34-S35
article
917 Reduction of pertechnetate by chemical and photochemical approaches and incorporation of Tc(IV) into titanium dioxide for wasteform development Salcedo, Ramsey

100-101 S p. S7
article
918 Reductive N-11C-methylation of anilines in dimethyl sulfoxide using in situ generated [11C]formaldehyde and 2-methylpyridine-borane Zhang, Ming-Rong

100-101 S p.
article
919 Re/99mTc complexes of 1,8-naphthalimide with varying linkers as dual-modality imaging agents Prabhu, Priyanka Jagadeesa

100-101 S p. S41-S42
article
920 Replacing high-performance liquid chromatography (HPLC) with high-resolution thin layer chromatography (TLC) for rapid radiopharmaceutical analysis Holloway, Travis

100-101 S p. S63
article
921 Reports on the advancements of organotrifluoroborates and their use in PET imaging Lozada, Jerome

100-101 S p.
article
922 Rhenium and technetium complexes in extremely low oxidation states Salsi, Federico

100-101 S p. S3-S4
article
923 Same-day solid target productions of clinically relevant quantities of 89Zr, 61Cu, and 68Ga by a single operator using a single chemistry module Svedjehed, Johan

100-101 S p.
article
924 Scale-up and optimisation of 199Au production from natPt0 and successful 199Au-labelling of bis-pyridine Rosecker, Veronika

100-101 S p.
article
925 Scale up production and purification of high specific activity lead-203 (203Pb) Saini, Shefali

100-101 S p.
article
926 Scandium-47 and lutetium-177 radiolabelling and stability studies of 1st and 2nd generation DOTA-triphenylphosphonium ligands – potential radionuclide theranostics for treatment of glioblastoma multi-forme Wyatt, Naomi

100-101 S p. S93-S94
article
927 Scandium exopolysaccharide complexes: evaluation of antiproliferative properties of on several cancer cell lines Munoz-Garcia, Javier

100-101 S p. S195-S196
article
928 Scandium(III) and macrocyclic cavity of DOTA-like ligands: implications for design of chelators for scandium radioisotopes Urbanovsky, Peter

100-101 S p. S68
article
929 (S)-2-(3-(carboxymethyl)ureido)-3-((2-hydroxy-3,4-dioxocyclobut-1-en-1-yl)amino)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging Liu, Tianqing

100-101 S p.
article
930 SCIFI: exciting BODIPY compounds with 89Zr-generated Cerenkov radiation Gristwood, Katie

100-101 S p. S167
article
931 Separation of cyclotron-produced cobalt-55/58 m from iron targets using cation exchange chromatography Lin, Wilson

100-101 S p.
article
932 Short PEG linkers considerably reduce background noise in immuno-PET tumor imaging Nam, Bora

100-101 S p. S207
article
933 Silicon-based Fluoride Acceptor (SiFA) on solid supports: a new versatile tool for 18F-fluorination of peptides and biological structures Steffann, Marine

100-101 S p. S87
article
934 Simple and quick indirect radioiodination to antibody without HPLC purification using fluorous solid-phase extraction and click reaction Im, Changkeun

100-101 S p. S125-S126
article
935 Simple and rapid automated synthesis of L-[11C]glutamine Fujinaga, Masayuki

100-101 S p. S124-S125
article
936 Simple method for the production of [11C]phosgene Krzyczmonik, Anna

100-101 S p. S72-S73
article
937 Site-selective 18F-labelling of octreotide via disulfide rebridging Richard, Mylène

100-101 S p. S86
article
938 Site-selective labelling of biomolecules via disulfide rebridging Richard, Mylène

100-101 S p. S4
article
939 Site-specifically THP-functionalized hPD-L1 single-domain antibody: preliminary data toward kit development Dierick, Herlinde

100-101 S p.
article
940 Site-specific [68Ga]Ga radiolabelling of antibodies through methionine conjugation Chi Yue, Thomas Tin

100-101 S p.
article
941 Site-specific radiofluorination of peptides via chemoselective S-arylation with 4-[18F]Fluoroiodobenzene Francis, Felix

100-101 S p. S116
article
942 Site-specific radiolabeling of an anti-HER2 single domain antibody fragment with an 211At-labeled prosthetic agent: preliminary evaluation of a potential targeted α-particle therapeutic Feng, Yutian

100-101 S p. S32
article
943 Site-specific 89Zr-labeling of a VHH construct as a half-life extending building block for PET and TRNT applications Leekens, Simon

100-101 S p.
article
944 Small-molecule antagonist radiotracers for positron emission tomography imaging of the mu opioid receptor. Plakas, Konstantinos

100-101 S p.
article
945 Small molecule-based angiogenic radiotracer for early detection and progression management of pulmonary arterial hypertension Yang, Zhen

100-101 S p. S67
article
946 Solid phase radiosynthesis of an 18F labeled olaparib derivative for PET imaging of PARP expression Zhou, Dong

100-101 S p. S222
article
947 Solid polyamine adsorbents for [11C]CO2 capture, purification, and radiosynthesis Chasse, Melissa

100-101 S p. S23
article
948 Sortase mediated conjugation and 89Zr-radiolabelling of the HER2 neu targeting G3-DARPin for in vivo PET imaging in BT-474-xenografts Fay, Rachael

100-101 S p. S89-S90
article
949 SPAAC incorporation of fluorine into FC131 analogues towards discovery of CXCR4 radiopharmaceuticals Mason, Julia

100-101 S p. S202-S203
article
950 Specific imaging of bacterial infections with 18F-labeled maltotriose ([18F]AAX90) Landau, Felicitas

100-101 S p. S8
article
951 Stabilization of 68Ga-labeled [Thz14]Bombesin(7–14) analogue for imaging gastrin-releasing peptide receptor expression with positron emission tomography Wang, Lei

100-101 S p.
article
952 StarPEG Nanocarriers for Prostate Cancer Imaging and Drug Delivery Meher, Niranjan

100-101 S p.
article
953 StarPEG Nanocarriers for PSMA Targeted Radioligand Imaging and Therapy Bidkar, Anil

100-101 S p.
article
954 Structure-activity relationship of pyrazol-4-yl-pyridine derivatives for imaging the muscarinic acetylcholine receptor M4 Haider, Ahmed

100-101 S p. S25
article
955 Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate Rahimi, Marwa

100-101 S p. S107
article
956 Studies of [89Zr]ZrDFO*-Labeled Human Serum Albumin Applying Different Cysteine Bioconjugation Chemistry Kronberger, Julia

100-101 S p.
article
957 Studies on the novel scandium-47 labelled PSMA inhibitor targeting ligand Wojdowska, Wioletta

100-101 S p. S102
article
958 Studying the effect of structural modification of porphyrin derivatives on tumor uptake: Is lipophilicity the sole criterion? Guleria, Mohini

100-101 S p. S45-S46
article
959 Study of radiolabeled hepatotropic peptide derivatives for the diagnosis and treatment of hepatocellular carcinoma Nahas, Hanadi

100-101 S p. S41
article
960 Study of radiolabeled nanoplastics: synthesis and in vitro stability evaluation of Cu-64 and Lu-177 labeled polypropylene (PP) Kim, Heejung

100-101 S p.
article
961 Subtype-selective vasopressin 1A receptor imaging by positron emission tomography Haider, Ahmed

100-101 S p. S58
article
962 Supramolecular chemistry in the synthesis of radiopharmaceuticals d’Orchymont, Faustine

100-101 S p. S34
article
963 Survey of the use of yttrium-90 in selective radiotherapy for primary liver cancer treatment Tuan, Hoang

100-101 S p. S48
article
964 Syntheses and biological evaluation of two F-18 radiotracers for imaging MLKL in the brain Huang, Tianyu

100-101 S p.
article
965 Synthesis and Astatine Labeling of a bis-iminobiotin derivative with enhanced plasma stability Washiyama, Kohshin

100-101 S p. S121
article
966 Synthesis and bioevaluation of a novel SPECT agent targeting breast cancer estrogen receptor Lin, Xiaoru

100-101 S p. S53
article
967 Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity Nag, Sangram

100-101 S p. S26
article
968 Synthesis and biological evaluation of 1-[2-(cyclopentadienyltr icarbonyltechnetium-99m)-N-vanillyferrocenecarboxamide for tumor imaging Dallegi, Tesnim

100-101 S p. S51
article
969 Synthesis and characterization of new hydrophilic trithiol chelates and their radioarsenic complexes Ma, Li

100-101 S p. S30
article
970 Synthesis and characterization of novel enrofloxacin derivatives and their rhenium and technetium-99m tricarbonyl complexes as potential therapeutic or diagnostic agents Tzovas, Georgios

100-101 S p. S99
article
971 Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Radioligand Therapy Applications Muzzioli, Riccardo

100-101 S p.
article
972 Synthesis and evaluation of a bivalent radiohapten for DOTA-based pretargeted radioimmunotherapy Veach, Darren

100-101 S p. S61-S62
article
973 Synthesis and evaluation of a fluorinated PET imaging probe targeting fibroblast activation protein (FAP) Filippi, Nicolò

100-101 S p.
article
974 Synthesis and evaluation of a [68Ga]Ga-labeled water soluble porphyrin as a tumor targeting theranostic agent: in-vitro and in-vivo studies Kumar, Naveen

100-101 S p. S183-S184
article
975 Synthesis and evaluation of a 68Ga-labeled PSMA-targeting tracer with a rigid linker to reduce kidney and salivary gland uptake Kuo, Hsiou-Ting

100-101 S p.
article
976 Synthesis and evaluation of an 18F labeled conformationally flexible benzamide analog ([18F]Fluoroethyl HY-2-92) for D3R PET Studies Kim, Ho Young

100-101 S p. S96-S97
article
977 Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography Lu, Kelly

100-101 S p.
article
978 Synthesis and evaluation of a novel PET tracer for imaging monoamine oxidase-B Fujinaga, Masayuki

100-101 S p.
article
979 Synthesis and evaluation of a radioligand for PET imaging of hepsin Park, Ji-Hun

100-101 S p. S183
article
980 Synthesis and evaluation of 18F-labeled tracer candidates targeting the Abelson non-receptor tyrosine kinase in Parkinson’s disease Stéen, E. Johanna

100-101 S p. S27
article
981 Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for amyloid PET-imaging Schlein, Eva

100-101 S p. S101-S102
article
982 Synthesis and evaluation of 68Ga-labeled [Leu13ψThz14] Bombesin(7-14) analogues for imaging gastrin-releasing peptide receptor expression with positron emission tomography Wang, Lei

100-101 S p. S219
article
983 Synthesis and Evaluation of Modified NOTA Chelators Labeled with [99mTc]Tc/Re-Tricarbonyl for Potential Theranostic Agent Development Kamboj, Ritin

100-101 S p.
article
984 Synthesis and evaluation of novel 18F-labeled indole-based derivatives as sigma-2 receptor radioligands for imaging the proliferative status of tumors Zhang, Ying

100-101 S p. S197
article
985 Synthesis and evaluation of novel PET ligands for imaging Orexin2 receptor (OX2R) Rong, Jian

100-101 S p. S101
article
986 Synthesis and evaluation of PET ligands for monoacylglycerol lipase in brain Mori, Wakana

100-101 S p. S99
article
987 Synthesis and evaluation of [186Re]Re(CO)3-p-NCS-benzyl-NODAGA-Ser2-RM2 for future development as a GRPR-antagonist for targeting prostate cancer Hoerres, Rebecca

100-101 S p. S90-S91
article
988 Synthesis and in vitro and in vivo evaluation of a new 64Cu-semicarbazone complex: potential theranostic radiopharmaceutical for hypoxic tumor Aljammaz, Ibrahim

100-101 S p. S52
article
989 Synthesis and in vitro stability evaluation of Cu-64 labeled branched polyethyleneimine (BPEI) Choi, Se-hwan

100-101 S p.
article
990 Synthesis and in vitro stability evaluation of Cu-64 labeled linear polyethylenimine (LPEI) as a preliminary study Jang, Jaebaek

100-101 S p.
article
991 Synthesis and in vivo characterization of a heterobivalent radiotracer targeting PSMA and GRPR for prostate cancer imaging Bailly, Thibaud

100-101 S p. S177-S178
article
992 Synthesis and optimization of radiotracers targeting P2Y12 receptors for positron emission tomography imaging of neuroinflammation Pincemail, Eugénie

100-101 S p. S99-S100
article
993 Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor Högnäsbacka, Antonia

100-101 S p. S38-S39
article
994 Synthesis and preclinical evaluation of [18F]DASA-10 a second generation PKM2 specific radiotracer Beinat, Corinne

100-101 S p.
article
995 Synthesis and preclinical evaluation of [methylpiperazine-11C]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors Högnäsbacka, Antonia

100-101 S p. S51-S52
article
996 Synthesis and preclinical evaluation of 99mTc sandwich complexes targeting LAT1 and CRBN Sadeghi, Saman

100-101 S p. S32
article
997 Synthesis and preclinical evaluation of PD-L1 PET tracer [18F]FDHPA in mice Tong, Jie

100-101 S p. S214
article
998 Synthesis and Preclinical Evaluation of Three Novel 68Ga-labeled PSMA-FAP Heterodimeric Tracers for Imaging of Prostate Cancer Wang, Lei

100-101 S p.
article
999 Synthesis and preliminary evaluation of novel aminoimidazoline derivatives targeting the norepinephrine transporter Lu, Jie

100-101 S p. S199
article
1000 Synthesis and preliminary in-vitro studies of [99mTc][TcN(PNP)]-biphosphonates as new bone-radiopharmaceuticals. Carpanese, Debora

100-101 S p. S44-S45
article
                             1155 results found
 
   next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands